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ABSTRACT 
 Serum amyloid A (SAA) is a small, evolutionarily well-conserved, acute-
phase protein best known as the protein precursor for amyloid A amyloidosis. 
During acute injury, infection, or inflammation, SAA plasma concentration rapidly 
rises 1000-fold, but the benefit of this dramatic increase is unclear. SAA functions 
in the innate immune response, cell signaling, and lipid homeostasis. Most SAA 
circulates on plasma high-density lipoproteins (HDL), where it reroutes HDL for 
lipid recycling. The aim of this dissertation is to provide a structural basis for 
understanding SAA-lipid interactions and to elucidate the structure-function 
relationship in this ancient protein.  
SAA is an intrinsically disordered protein that acquires ~50% helical 
structure when bound to lipids, and is ~80% helical in three available atomic-
resolution x-ray crystal structures. We took advantage of these crystal structures 
of lipid-free SAA to propose the binding site for various lipids, including lipids in 
HDL. We postulated that SAA, as a monomer, binds lipids via two amphipathic 
helices, h1 and h3, that form a concave hydrophobic surface, and that the 
 
 vi 
curvature of this surface defines the binding preference of SAA for HDL versus 
larger lipoproteins.  
 Next, we used murine SAA1.1 and a membrane-mimicking model 
phospholipid, palmitoyl-oleoyl phosphocholine (POPC), to reconstitute SAA-lipid 
complexes and characterize their overall structure, stability and stoichiometry 
using an array of spectroscopic, electron microscopic, and biochemical methods. 
We observed preferential formation of ~10 nm particles that mimic HDL size, 
accompanied by the α-helical folding. 
 To probe the local protein conformation and dynamics in these SAA-POPC 
particles, we used hydrogen-deuterium exchange mass spectrometry. Analysis of 
the amount and the kinetics of deuterium uptake clearly established h1 and h3 as 
the lipid-binding site. Moreover, we determined that SAA binding to lipid follows a 
mixed model that combines induced fit, promoting α-folding in h3, with 
conformational selection, stabilizing pre-existing conformations in h1 and around 
the h2-h3 linker. Taken together, our results provided the structural basis 
necessary for understanding SAA-lipid interactions, which are central to beneficial 
functions of SAA as a housekeeping molecule, and to its misfolding in amyloid. 
This research sets the stage for understanding SAA interactions with its numerous 
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CHAPTER ONE: Introduction 
1.1 Serum amyloid A protein family is associated with inflammation  
Serum amyloid A (SAA, 103-112 amino acids) is an ancient family of proteins 
that has been highly conserved since the Cambrian explosion, from echinoderms 
and mollusks to rodents and primates, including humans (Uhlar et al. 1994; Uhlar 
& Whitehead, 1999; Kisilevsky & Manley, 2012). SAA is perhaps best known as 
the protein precursor of amyloid A (AA) amyloidosis, a life-threatening complication 
of chronic inflammation wherein N-terminal fragments of SAA (e.g. residues 1-76) 
deposit as fibrils in vital organs, mainly the kidney, spleen, and liver, leading to 
organ failure (Simons et al. 2013; Westermark, Fandrich & Westermark 2015). 
SAA plasma level is a clinical marker of inflammation due to a large increase in its 
hepatic secretion during inflammation.  
Within hours of the onset of acute injury, inflammation or infection, SAA 
concentration in plasma increases up to 1,000-fold, reaching concentrations over 
1 mg/ml (Gabay & Kushner, 1999; Uhlar & Whitehead, 1999; Urieli-Shoval et al. 
2000). This increase in SAA is a part of the complex immune response to injury, 
inflammation, and infection, termed the acute-phase response. Typically, during 
the acute-phase response, SAA concentration rapidly increases in the span of 24-
48 hours and then drops. The advantage for survival of this dramatic but transient 
increase remains unclear and is in the focus of our laboratory’s studies on SAA.  
In contrast to the dramatic elevation in levels of circulating SAA during acute-




in autoimmune diseases including rheumatoid arthritis and Crohn’s disease; in 
certain cancers; and in infections, such as tuberculosis (Gabay & Kushner, 1999; 
Cocco et al. 2009; Pierce et al. 2009, Liu et al. 2012; Menschikowski et al. 2013; 
Ye & Sun, 2015; Knebel et al. 2017; Sack, 2018). Persistently elevated levels of 
SAA are a major causative risk factor for AA amyloidosis, and have also been 
linked to atherosclerosis (O’Brien et al. 2005; Dong et al. 2011; Eklund et al. 2012; 
Thompson et al. 2015).  
 
1.2 SAA isoforms  
Humans have four SAA genes; SAA1 and SAA2 code for acute-phase 
isoforms, SAA3 is an apparent pseudogene due to a premature stop codon, and 
SAA4 codes for a constitutively expressed isoform (Kluve-Beckerman et al. 1991; 
De Beer et al. 1995; Uhlar & Whitehead, 1999; Gabay & Kushner, 1999; Tomita et 
al. 2015). In other species, including mice, Saa3 is efficiently translated. In mice, 
SAA3 is a third acute-phase isoform, similar to SAA1 and SAA2 (Tannock et al. 
2018). Acute-phase proteins SAA1 and SAA2 are primarily synthesized by 
hepatocytes under the control of pro-inflammatory cytokines, specifically 
interleukin-1β, interleukin-6, and tumor necrosis factor-α, and are secreted into 
plasma where SAA associates with lipoproteins (Kisilevsky & Manley, 2012; Sun & 
Ye, 2016). SAA is also expressed locally in tissues. In mice, SAA3, like other acute-
phase isoforms, binds to high-density lipoproteins (HDL), which is the major 




to HDL is addressed in this dissertation and in other recent studies from our 
laboratory. In these studies, we use murine SAA1.1 (mSAA1), a major isoform that 
binds HDL and forms amyloid in vivo. mSAA1 is highly homologous to its human 
counterpart and shows similar physicochemical and structural properties but is 
more soluble, facilitating its biophysical studies (Jayaraman et al. 2015; Frame & 
Gursky, 2016; Frame et al. 2017; Jayaraman et al. 2018).  
 
1.3 SAA misfolding in AA amyloidosis is influenced by lipids 
AA amyloidosis is a life-threating systemic disease that affects individuals with 
chronic inflammation. The disease is characterized by the accumulation of N-terminal 
fragments of SAA (termed AA), as fibrils with the cross-β-sheet structure characteristic 
of amyloid (Liberta et al. 2019). The AA fibrils deposit in vital organs, primarily the 
kidney, liver and spleen, and thereby damage them, ultimately leading to organ failure. 
Removal of AA deposits by anti-inflammatory treatments usually helps restore the 
organ function, but untreated AA amyloidosis can lead to death. (Westermark, 
Fandrich, & Westermark, 2015; Claus et al. 2017; Claus et al. 2017; Papa & 
Lachmann, 2018) 
Binding to HDL protects SAA from misfolding into amyloid both in vivo and in vitro 
while lipid-free SAA is proposed to be the protein precursor of AA amyloid (Norborn 
et al. 2012; Simons et al. 2013; Jayaraman et al. 2015; Claus et al. 2017). Cell-based 
studies in the laboratory of our collaborator, Dr. Marcus Fandrich, as well as 




enhanced retention of SAA on HDL or other lipoproteins stabilizes the α-helical 
structure and protects it from misfolding into cross-β-structure in amyloid. At near-
neutral pH, formation of amyloid depends on the dissociation of SAA from HDL, which 
can be achieved by various factors, including SAA interactions with heparan sulfate 
proteoglycans (Ancsin & Kisilevsky, 1999; Norborn et al. 2012) or elevated levels of 
HDL triglycerides (Jayaraman et al. 2017). 
Recent studies have shown that at low pH, lipids are critical to the initiation of AA 
amyloidosis. Biophysical studies by Dr. Shobini Jayaraman from our laboratory 
demonstrated that in contrast to neutral pH, at pH 4.3, free SAA has α-helical content 
at room temperature. Upon the addition of lipid vesicles at pH 4.3, SAA undergoes an 
α-helix to β-sheet transition and lyses lipid bilayers (Jayaraman et al. 2017). This 
provides the biophysical basis for cell-based studies showing that internalization of 
SAA by monocytes and the resulting lysosomal processing induces β-folding and 
amyloid formation, which disrupts the cellular membrane and leads to cell death 
(Claus et al. 2017; Vahdat Shariat Panahi et al. 2019). Together, these studies 
strongly support the lysosomal origin of AA amyloidosis and the essential role of the 
lipid membrane in the initiation of the misfolding (Shirahama & Cohen, 1975). 
Even though lipids critically influence both normal functions of SAA and its 
pathological misfolding, the exact mechanism of SAA-lipid interactions remains 
elusive. In this dissertation, we establish the biophysical and structural basis for 





1.4 High-density lipoprotein is the major plasma carrier of SAA 
During inflammation, most circulating SAA, ~95%, is bound to the surface of 
HDL, though in conditions such as diabetes, SAA can also bind to low-density 
lipoproteins and very-low-density lipoproteins. (Benditt & Eriksen, 1977; Benditt, 
Eriksen, & Hanson, 1979; Coetzee et al., 1986; Jahangiri et al. 2013; Komiyama 
et al. 2016). HDL are heterogeneous particles, 8-12 nm in diameter, that remove 
excess cell cholesterol through the reverse cholesterol transport pathway and 
protect against atherosclerosis (van der Westhuyzen et al., 2007; Getz & Reardon, 
2008; Lund-Katz & Phillips, 2010). A nascent HDL particle is comprised of a 
cholesterol-containing phospholipid bilayer with amphipathic α-helices of 
apolipoprotein A-I (apoA-I, 28 kDa) wrapped around the perimeter in an antiparallel 
“double-belt” conformation (Gu et al. 2010; Phillips, 2013; Bibow et al. 2017). 
Nascent HDL is converted via the action of lecithin:cholesterol acyltransferase into 
a mature spherical particle. Mature HDL contains a core of apolar lipids, mainly 
cholesterol esters and triglycerides, a surface monolayer of polar lipids, mainly 
PCs and cholesterol, with apoA-I and additional apolipoproteins, including apoA-
II, apoE, and apoCs, embedded into the surface monolayer (Fig. 1.1  HDL cartoon) 
HDL solubility is conferred by its polar surface, which is comprised of PC head 
groups along with the polar faces of the apolipoprotein α-helices, while the apolar 








Figure 1.1 Cartoon illustrating the structure of mature HDL. 
HDL are heterogeneous particles 8-12 nm in diameter. Mature HDL has an 
apolar lipid core, comprised mainly of cholesterol esters and triglycerides, 
surrounded by a lipid monolayer of phospholipids and cholesterol. Apolipoprotein 
A-I and other apolipoproteins are embedded in the phospholipid monolayer via the 





During the acute-phase response, plasma levels of HDL decrease and both 
the protein and the lipid compositions of HDL are altered (Getz & Reardon, 2008; 
Jahangiri et al. 2009; Jahangiri, 2010; Han et al. 2016; Feingold & Grunfeld, 2016). 
One of the major changes is that SAA becomes the major apolipoprotein on acute-
phase HDL; as a result, the metabolism of SAA-containing HDL (SAA-HDL) is 
altered from the classical reverse cholesterol transport pathway.  
Perhaps the best-understood function of SAA is its ability to mobilize 
phospholipids and cholesterol for cell repair (Kisilevsky and Manley, 2012), which 
is critically hinged on SAA binding to HDL (Benditt and Eriksen, 1977; Coetzee et 
al., 1986). During the acute phase response, SAA reroutes HDL metabolism from 
cholesterol removal and excretion by the liver to cholesterol recycling used for cell 
repair. This occurs because SAA interacts with scavenger cell receptors, such as 
cluster differentiation 36 scavenger receptor (CD36), oxidized low-density 
lipoprotein receptor 1 (LOX-1) and receptor for advance glycation end products 
(RAGE), which bind modified but not normal HDL (van der Westhuyzen et al., 
2007; Perrone et al., 2008; Kisilevsky and Manley, 2012; Ye and Sun, 2015). This 
facilitates the uptake of SAA-HDL by a wide range of cells that typically do not 
internalize unaltered HDL; such cells include arterial macrophages. The uptake of 
these modified HDL by arterial macrophages can initiate the formation of foam 
cells and lead to atherosclerosis, which probably contributes to the link between 
elevated plasma SAA and the risk of atherosclerosis (King et al. 2011; Dong et al. 




accelerates the progression of atherosclerosis in mouse models (Thompson et al. 
2015, Dong et al. 2011), further highlighting the link between SAA and lipid 
homeostasis. 
 
1.5 SAA binds and solubilizes various lipids 
In addition to binding existing lipoproteins, SAA can generate lipoproteins de-
novo by sequestering lipids from the plasma membrane. SAA-only lipoproteins are 
present in both apoA-I -/- and apoA-I +/+ mice upon induction of the acute phase 
response (Cabana et al. 1999). SAA can also stimulate cholesterol efflux from cells 
both independent and dependent on ABCA-1 and ABCA-7, which are two lipid 
transporters that facilitate HDL formation in vivo (Stonik et al. 2004; Abe-Dohmae 
et al. 2006; Hu et al. 2008). Moreover, recent studies from two laboratories 
including ours, have shown that SAA binds a wide range of lipids, including but not 
limited to phospholipids and their hydrolytic products, and forms lipoprotein-like 
particles (Frame et al. 2017; Jayaraman et al. 2018; Takase et al. 2019). Although 
the functional role of these SAA-only lipoproteins remains unclear, their formation 
suggests that SAA may serve as a housekeeping molecule acting as an acceptor 
of lipids from the sites of inflammation (Stonik et al., 2004). Recent studies from 
our laboratory show that SAA works in tandem with secretory phospholipase A2, 
another acute-phase protein, to perform this function (Jayaraman et al., 2019). 
These studies compelled our team to propose that the ability to bind and solubilize 




of SAA as a lipid scavenger from the damaged and dead cells (Jayaraman et al., 
2019). The studies presented in this dissertation help establish the structural basis 
for understanding this key function of SAA.  
 
1.6 SAA interacts with a wide range of functional ligands 
Besides its role in lipid homeostasis during inflammation, SAA is important in 
multiple physiological processes including cytokine regulation and immune cell 
recruitment (Eklund et al. 2012; Ye & Sun, 2015), retinol transport (Derebe et al. 
2014), and cellular signaling (Sack, 2018 & references therein). We postulate that 
these diverse functions of SAA stem from its ability to interact with a wide range of 
functional ligands. These include hydrophobic ligands such as HDL and other 
plasma lipoproteins (Benditt & Eriksen, 1977; Coetzee et al., 1986; Jahangiri et al. 
2013; Komiyama et al. 2016), model liposomes comprised of diverse 
phospholipids and their hydrolytic products (Takase et al. 2014; Jayaraman, 2015; 
Jayaraman, 2018), cholesterol (Liang et al. 1996) and retinol (Derebe et al. 2014); 
charged ligands, including both cationic (metal ions) (Wang & Colon, 2007) and 
anionic (heparan sulfate proteoglycans) (Ancsin & Kisilevsky, 1999; Norborn et al. 
2012); and numerous proteins including various cell receptors. These receptors 
include SR-BI (Cai et al. 2005; van der Westhuyzen et al. 2005) that interacts 
productively with both normal and SAA-containing HDL (SAA-HDL), or CD36 and 
LOX-1 that preferentially bind and internalize modified lipoproteins including SAA-




small protein, only 104 residues, having this diversity in binding partners is quite 
striking. We propose that this ligand binding promiscuity likely stems from the 
structural flexibility of SAA.  
 
1.7 SAA is an intrinsically disorder protein 
SAA is an intrinsically disordered protein (IDP) as it has a substantially 
disordered secondary structure at near-physiologic conditions in the absence of 
bound ligands (Takase et al. 2014; Wang et al. 2011). The secondary and 
quaternary structures of SAA strongly depend on environmental conditions such 
as temperature, solvent ionic conditions, and the presence of ligands. At near-
physiologic conditions, lipid-free murine mSAA1 is ~25-30% α-helical and self-
associated at 5°C, but this helical structure unfolds by 25°C (Fig. 1.2) and 
oligomers are disrupted upon heating to 37°C (Jayaraman et al. 2015). Although 
the unfolded ligand-free forms of SAA in solution have been observed in many in 
vitro studies, it is unclear whether this species exists in vivo. Such unfolded states 
are expected to be only transiently present in vivo as they are highly susceptible 
to proteolysis and misfolding. 
Ligand binding and folding are often coupled in IDPs (Wright & Dyson, 2009; 
Ferreon et al. 2013) and SAA is no exception. In SAA, binding to phospholipids 
and lipoproteins, including HDL, is coupled with α-helical folding (Takase et al. 





Figure 1.2 Secondary structure and thermal stability of lipid-free and lipid-
bound SAA. 
Far-UV CD spectra at 25°C (left panel) show that lipid-free SAA is largely unfolded, 
while lipid-bound SAA in SAA-POPC complexes acquires substantial helical 
structure. Thermal unfolding data (right panel) recorded by CD at 222 nm to 
monitor α-helical structure upon heating at a constant rate  show that the melting 
temperature of SAA-POPC, Tm~52°C, is much higher than that of free SAA, 






reconstituted from mSAA1 and phosphatidylcholine in vitro, mSAA1 acquires ~45-
55% α-helical content and remains stable upon heating above 37°C (Fig. 1.2). The 
structure and stability of the model SAA-lipid complexes have been explored in 
several studies by our laboratory and are described in this dissertation. 
 
1.8 X-ray crystal structures of SAA 
X-ray crystal structures at resolutions as high as 2 Å were determined for lipid-
free human and murine SAA in three different forms: hSAA1 hexamer (PDB ID 
4IP9), hSAA1 dimer of dimers (PDB ID 4IP8), and mSAA3 tetramer (PDB ID 
4Q5G) (Lu et al. 2014; Derebe et al. 2014) (Fig. 1.3). Notably, despite the 
differences in SAA isoform, as well as in the protein self-association and crystal 
packing, monomer folds in each of the crystal structures are all very similar, 
suggesting that this molecular fold is conserved in the SAA family. Overall, the SAA 
monomer forms a unique Y-shaped 4-helix bundle with a ~70-80% α-helical 
content. The bundle is comprised of helices h1 (residues 1-27), h2 (32-47), h3 (50-
69), and h4 (73-88), and is stabilized by the polar C-terminal (CT) tail (residues 89-
104) containing a short 3/10 helix h’ (91-96) that interacts with h1 and h2 via 
multiple hydrogen bonds and salt bridges (Fig. 1.4) (Lu et al. 2014; Derebe et al. 
2014). The structure is further stabilized by electrostatic interactions involving 






Figure 1.3 X-ray crystal structures of human and murine SAA display 
different packing of protein oligomers. 
The structures of hSAA1 and mSAA3, crystallized in three different lattices, were 
determined to 2-2.5 Å resolution (Lu et al. 2014; Derebe et al. 2014). hSAA1 was 
crystallized as a hexamer (PDB: 4IP9) or a tetramer (PDB: 4IP8 ) and mSAA3 was 






Figure 1.4 Crystal structures of SAA have very similar monomer fold. 
A) Ribbon diagram of hSAA1 monomer (PDB: 4IP8) shows a Y-shaped 4-helix 
bundle. Diagram is colored as follows: h1 in blue, h2 in cyan, h3 in green, h4 in 
orange, and C-terminal tail in red. * indicate three predicted amyloidogenic 
segments located in h1 and h3 (Das & Gursky, 2015). 
B) Cartoon schematic of hSAA1 helices seen in the crystal structure; h1 (1-27), 
h2 (31-47), h3 (51-69), h4 (73-88) and h’ (91-96). 





Since SAA is lipophilic, defining its hydrophobicity is an important aspect of its 
structure-function relationship (Frame & Gursky, 2016) and will be discussed in 
detail in this dissertation.  Hydrophobic surfaces are not only the most likely to be 
involved in lipid binding, but are also the most likely to be buried in the interior of 
the lipid-free protein. The fact that the 4-helix bundle of SAA has a polar interior 
and lacks a hydrophobic core typical of other helix bundles, such as apoA-I, is 
unique. This suggests that SAA relies on oligomerization to protect and bury these 
hydrophobic residues. Interestingly, each of the oligomers had intermolecular 
contacts between the h1 and h3 helices. 
The monomer fold solved by X-ray crystallography is in general agreement 
with the earlier structural predictions based on the amino acid sequence analysis 
(Stevens, 2004).  Through BLAST searches of the SAA1 and SAA2 sequences, 
SAA was proposed to have sequence homology to the N-terminal domain of 
hemocyanin from arthropods. Using an already determined structure of the N-
terminal domain of hemocyanin, Stevens suggested that up to 80% of the SAA 
monomer is inherently α-helical and that the unordered structure is located mainly 
in the C-terminal tail. Though the exact number of helices in SAA and its tertiary 
packing could not be determined using the modeling algorithms, the fact that the 
predicted structure is in general agreement with the crystal structure further 
confirms that the fold is not an artifact of the crystal packing but an intrinsic property 




evidence that, despite the IDP character of SAA, the crystal structure is highly 
relevant to its solution conformation in lipid-free and lipid-bound forms. 
 
1.9 How does SAA bind to various lipids and HDL? 
Previous studies of SAA-lipid interactions were mainly focused on cholesterol and 
HDL. Antibody competition assays have identified residues 1-18 in h1 as the major 
binding site for cholesterol in SAA (Ziq-Bahar et al. 1991; Liang et al. 1996). In addition 
to the inhibition of cholesterol binding by an antibody to residues 1-18, a smaller 
reduction in binding was also observed in the presence of an antibody to residues 40-
63 (Liang et al. 1996). To further refine the lipid-binding site, in vitro peptide binding 
experiments to liposomes were used. In these studies, smaller peptides 
encompassing different regions of the protein were used, and the lipid-induced helical 
folding was monitored as an indicator of lipid binding. The N-terminal fragment of the 
peptide, encompassing residues 1-27, was the only region that underwent α-helical 
folding. Through additional mutation analysis, the binding region was further refined 
to amino acids 1-11 (Ohta et al. 2009).  
More recently, the hexamer observed in one crystal structure of hSAA1.1 (PDB 
ID 4IP9) was proposed to represent the HDL-bound form. Since heparan sulfate 
proteoglycan binding interferes with HDL binding (Ancsin & Kisilevsky, 1999; Noborn 
et al. 2012), two positively charged triads in the hexamer, one in the center and one 
at the apex, which could facilitate the heparan sulfate proteoglycan interactions, were 




binding, all three amino acids of each triad were mutated to alanine and the binding 
to HDL was measured using surface plasmon resonance. The charged triad at the 
apex composed of Arg 1, Arg 62 and His 71, was proposed to be responsible for 
binding to HDL (Lu et al., 2014).  However, we noticed that this idea has several flaws 
(Frame & Gursky, 2016): (i) the SAA hexamer lacks a large contiguous apolar surface 
that is prerequisite for HDL binding, as apolar faces are buried in the interior of the 
protein; (ii) the HDL surface, which is comprised mainly of phosphatidylcholine and 
cholesterol, is uncharged yet the proposed HDL binding site on the hexamer is 
charged; (iii) this site is not selective for HDL; (iv) cross-linking studies showed that 
the SAA hexamer must dissociate into monomers to bind HDL (Wang & Colon, 2004).  
 In summary, previous studies provided strong evidence that h1 of SAA 
contributes to the binding of lipids, including cholesterol and HDL. However, h1 is not 
solely responsible for the binding, as N-terminal deletion does not completely 
eliminate HDL binding (Patel et al. 1996). This highlights the need to better 
characterize the lipid-binding site in SAA, which is one of the major goals of this 
dissertation.  
 
1.10 Scientific aims of this research  
SAA is a lipophilic protein whose major plasma carrier is HDL. Previous 
studies by many teams provided extensive evidence for the central role of lipids in 
normal functions of SAA during inflammation as well as its pathologic misfolding in 




was still lacking. The exact lipid binding site in SAA was not known, the basis for 
preferential binding of SAA to HDL as opposed to other lipoproteins was lacking, 
and the properties of model SAA-only lipoproteins were just beginning to be 
elucidated by a handful of teams including ours. Therefore, the aim of this 
dissertation was to provide a detailed mechanistic understanding for SAA-lipid 
interactions.  
The studies described in Chapter 3 focused on sequence and structural 
analyses of SAA proteins, which enabled us to propose a complete lipid-binding 
site in SAA to explain its preferential binding to HDL (Frame & Gursky, 2016). This 
binding site was then experimentally confirmed through hydrogen-deuterium 
exchange mass spectrometry studies described in Chapter 5 (Frame et al., in 
preparation). In these studies, we used stable homogeneous model complexes of 
SAA and lipid, which were obtained and characterized in detail in Chapter 4 (Frame 
et al., 2017). Taken together, our results have provided unprecedented insights 
into the conformations of SAA, both lipid-free in solution as well as bound to 
lipoproteins. Moreover, the work established a structural basis for understanding 
the interactions of this intrinsically disordered protein not only with various lipids 







CHAPTER TWO: Materials and Methods 
2.1 Materials 
2.1.1 Proteins 
 We used murine serum amyloid A isoform 1.1 (mSAA1), the major acute-
phase isoform that binds HDL and forms amyloid in vivo. Recombinant full-length 
mSAA1, with the N-terminal Gly truncated, was provided by Drs. Christian Haupt 
and Märcus Fandrich from Ulm University. The proteins were expressed in 
Escherichia Coli and purified to >95% purity through multiple steps, including both 
nickel and reverse phase chromatography, as previously described (Kollmer et al., 
2016).  mSAA1 has 75% amino acid sequence identity with human SAA1.1 
(hSAA1); the major differences reside in the N-terminal amino acids. The murine 
protein is less prone to aggregation as compared to the human ortholog and its 
improved solubility is useful for experimental studies, especially those requiring 
high protein concentrations.  
Each batch of lyophilized mSAA1 was stored at 4°C. Before use, lyophilized 
mSAA1 was dissolved in double-distilled H2O to an initial concentration of ~20 
mg/ml for full-length SAA. For each experiment, appropriate dilutions of the protein 
stock were made with 10 mM sodium phosphate buffer at pH 7.5, the standard 
buffer used throughout this work. No additional salt was added to the buffer 
solution in order to achieve maximal solubility of SAA for our experiments. Previous 






 mSAA1 was reconstituted into binary, ternary, or quaternary lipid-protein 
complexes with one or more of the following lipids: 1-pamitoyl-2-oleoyl-glyero-3-
phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol 
(POPG), phosphatidylserine (PS), 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
(DMPC), and unesterified cholesterol. All lipids (≥97% purity) were purchased from 
Avanti Polar Lipids and stored at -20°C. Lipid suspensions were dried under a N2 
stream and stored in a desiccator at 4°C prior to use.  
 
2.1.3 Lipoproteins reconstitution  
Lipoproteins were reconstituted using either spontaneous reconstitution or 
the cholate dialysis method following published protocols.  
 For spontaneous reconstitution, mSAA1 stock solution was mixed with 
small unilamellar lipid vesicles (SUV) at various molar ratios and incubated for at 
least 1 hour. The final molar ratios used in this work ranged from 1:0.5 SAA:lipid 
to 1:80 SAA:lipid. To form the SUV, the dried lipid film was resuspended in 2.5 ml 
of buffer. The lipid suspension was then sonicated as previously described 
(McLean and Phillips, 1981). The sonication tip was submerged in the solution and 
pulsed at a duty cycle of 30% and output 3 for 1 hour. After sonication, the solution 
appeared clear, which indicated the formation of small vesicles.  
 To form homogenous particles of controlled stoichiometry, the cholate 




1) lipid films containing 0.328 mg, 0.984 mg, or 2.62 mg POPC, which correspond 
to 1:10, 1:30, or 1:80 SAA:POPC molar ratios, were dried under N2 and 
resuspended in 200 µl buffer; 2) sodium deoxycholate was added to reach a final 
concentration of 19 mM and incubated until lipid was completely solubilized; 3) 0.5 
mg SAA was added to reach a final concentration of 1 mg/ml; 4) the mixture was 
incubated for 1 hr at 37°C; 5) the sample was dialyzed against buffer solution. This 
process resulted in the formation of homogenous particles with all the lipid 
incorporated into lipoproteins.  
 
2.1.4 Protein concentration determination 
 The SAA concentration was determined using UV/Vis absorbance 
spectroscopy. For the protein solution, the absorbance at 280 nm was measured 
using a 1 cm path length cell by a Varian Cary-300 UV/Vis spectrophotometer.  
From the UV absorbance at 280 nm, A280, the protein concentration can be 
calculated using Beers-Lambert Law: A280=ε*c*l, where ε is the extinction 
coefficient (in M-1 · cm-1), c is the concentration (in M), and l is the path length (in 
cm). The extinction coefficient is an intrinsic property of the protein determined by 
the amino acid composition. The extinction coefficient was calculated using the 





2.2 Bioinformatics and structural analysis   
 To understand the structural properties of SAA, bioinformatics analyses 
including sequence alignment, prediction algorithms for α-helical propensity, 
hydrophobicity, and transmembrane potential, as well as amino acid mapping onto 
the existing crystal structures were used. Each prediction algorithm assigned a 
numerical value to every amino acid that describes a specific property such as 
hydrophobicity (Table 2.1). The details of each of the analyses are outlined below. 
 
2.2.1 Sequence alignment 
 Different amino acid sequences of SAA proteins found in UniProt, including 
different isoforms and orthologs, were aligned using the multiple sequence 
alignment feature on the Clustal Omega server (Sievers et al., 2011). In total, 19 
protein sequences ranging in length from 103 to 112 amino acids were aligned 
(Table 2.2). The amino acid conservation was determined in comparison with 
hSAA1.  Alignment was displayed using Jalview (Waterhouse et al. 2009) 
 
2.2.2 Propensity for α-helix 
 The α-helical propensities of the 19 SAA sequences used in the alignment 
were obtained by using the ProtScale (Gasteiger et al., 2005) within the ExPASy 





Table 2.1 Numerical values assigned to individual amino acids in various 










  Levitt D&G Kyte & Doolittle Zhao & London 
Ala 1.290 1.489  1.800 0.380 
Arg 0.960 1.224 -4.500 -2.570 
Asn 0.900 0.772 -3.500 -1.620 
Asp 1.040 0.924 -3.500 -3.270 
Cys 1.110 0.966  2.500 -0.300 
Gln 1.270 1.164 -3.500 -1.840 
Glu 1.440 1.504 -3.500 -2.900 
Gly 0.560 0.510 -0.400 -0.190 
His 1.220 1.003 -3.200 -1.440 
Ile 0.970 1.003  4.500 1.970 
Leu 1.300 1.236  3.800 1.820 
Lys 1.230 1.172 -3.900 -3.460 
Met 1.470 1.363  1.900 1.400 
Phe 1.070 1.195  2.800 1.980 
Pro 0.520 0.492 -1.600 -1.440 
Ser 0.820 0.739 -0.800 -0.530 
Thr 0.820 0.785 -0.700 -0.320 
Trp 0.820 1.090 -0.900 1.530 
Tyr 0.720 0.787 -1.300 0.490 























































































algorithms by Levitt (1978), Deleage & Roux (1987), and Chou & Fasman (1978). 
All figures presented have been obtained by using the Levitt algorithm.   
 
2.2.3 Transmembrane tendency 
 The propensity to form transmembrane helices of 7 SAA sequences from 
human, mouse, rabbit, rat, and hamster were obtained using the ExPasy program 
ProtScale (Gasteiger et al., 2005). The Zhao & London scale (2006) was used to 
perform the analysis.  
 
2.2.4 Hydrophobicity profile 
 Hydrophobicity plots for 19 SAA sequences were obtained by using the 
Kyte-Doolittle scale (Kyte & Doolittle, 1982) found on the ProtScale tool of ExPASy 
Bioinformatics Resource Portal (Gasteiger et al., 2005). Other available 
hydropathicity scales give similar profiles but were not used in the analysis. 
 
2.2.5 α-helical wheel projections 
 Wheel projections of the α-helices were made using the canonical unit of 
3.6 amino acid residues per turn. Wheel diagrams for hSAA1 (Lu et al., 2014) and 




their crystal structures. The hydrophobic moment, µ, for each helix was calculated 
using an online server developed by Don Armstrong and Raphael Zidovetzki: 
(http://pss.sjtu.edu.cn/cgi-bin/wheel.cgi) 
 
2.2.6 Analysis of crystal structures in Chimera 
 The PDB files of the three available crystal structures of full-length lipid-free 
SAA, two of hSAA1 (PDB ID: 4IP8 and 4IP9, Lu et al., 2014) and one of mSAA3 
(PDB ID: 4Q5G, Derebe et al., 2014), were viewed using Chimera (UCSF, 2004). 
The resolution of these structures was 2-2.5 Å, with two protein molecules per unit 
cell. All analyses were done using the SAA monomer whose fold was very similar 
in all six crystallographically unrelated molecules from the three structures. 
 The hydrophobicity distribution was mapped onto the space-filling model of 
SAA monomer to identify contiguous apolar faces. The Kyte-Doolittle scale was 
used to color-code the amino acids, with gold representing apolar residues and 
gray representing polar residues. The dimensions of the hydrophobic surface were 
determined by using the Distances feature in the structural analysis tools of 
Chimera. Atoms at the edges of the surface were selected for the measurements.   
 Hydrogen bonds were identified using the FindHBond feature and distances 
were measured between specific atoms using the Distances feature within the 




2.3 Circular dichroism spectroscopy 
2.3.1 Background 
 Circular dichroism (CD) spectroscopy is a powerful technique to investigate 
the structure and stability of macromolecules and their complexes, including 
proteins and lipoproteins used in the current study. Linearly-polarized light can be 
represented as a sum of two components: left-handed circularly polarized light 
(lcp) and right-handed circular polarized light (rcp). These two components will be 
absorbed differently by chiral molecules, such as amino acids and proteins. CD 
reports on the difference in the absorption of lcp and rcp of a solution, ACD = Alcp - 
Arcp. The difference in absorption is proportional to ellipticity (θ) such that θdeg = 
33*ACD (Woody, 1996). The CD data are reported as ellipticity, which is normalized 
to eliminate the trivial dependence of absorbance on the protein concentration and 
cell path length described by Beers-Lambert law. The results in far-UV CD are 
presented as molar residue ellipticity, [θ].  
 Protein CD spectroscopy employs wavelengths in the UV range (180-350 
nm), which can be subdivided into far-UV (180-250 nm) and near-UV (250-350 
nm), and reports the average of the conformational ensemble in solution. Different 
protein groups as well as their local environments contribute to the signal in each 
of these UV ranges. The peptide group is responsible for the dominant signal in 





  The far-UV CD signal from the peptide group is due to two electronic 
transitions: ππ* and nπ*. For a single amino acid, these transitions are represented 
by a strong band at ~190 nm and a broad band centered at ~210 nm, respectively. 
An α-helical structure is most chiral and hence, has the strongest CD signal with a 
strong positive band centered at ~193 nm and two negative bands centered at 
~208 nm and 222 nm. The spectrum of β-sheets will usually have a positive peak 
at ~197 nm and a negative peak at ~218 nm. Random coil is the only structure that 
shows a negative peak at ~200 nm (Fig. 2.1) (Venyaminov & Yang, 1996; 
Kallenbach, Lyu, & Zhou, 1996; Tilstra & Mattice, 1996). Most proteins have a 
combination of secondary structure elements. In these cases, the CD spectrum is 
a mixture of the signals that can be deconvoluted to determine the relative amounts 
of each structure. Since α-helices have the strongest far-UV CD signal and are 
primarily responsible for the signal at 222 nm, for a predominantly -helical protein 
such as SAA, the helical content can be calculated based on the value of [222] 
(Mao, 1984).  
The characteristic CD features of the protein of interest can be monitored in 
thermal denaturation or melting experiments to determine the structural stability. 
In melting experiments, the protein is heated and cooled at a constant rate and its 
unfolding upon heating and refolding upon cooling is monitored using the CD signal 





Figure 2.1 Far-UV CD spectra of pure secondary structural elements in 
proteins.  
Adapted from (Bhagavan, 2002). The spectra were recorded from model peptides 
forming -helical, -sheet and random coil structures in solution.  
Far-UV spectra of proteins can be represented, to the first approximation, by a 






the intensity of the negative CD signal at 222 nm will decrease until the protein 
reaches the completely unfolded state. The melting temperature (Tm) can be 
determined from the midpoint (which is the inflection point for a simple sigmoidal 
transition) of the unfolding data, 222(T). The Tm is related to the free energy of the 
protein unfolding; proteins with a higher Tm are more thermodynamically stable 
than those with a lower Tm.  
By cooling the protein after unfolding and monitoring the refolding, the 
reversibility of the unfolding can be determined (Gursky & Atkinson, 1996; Gursky 
Ranjana, & Gantz, 2002). When the heating and cooling curves overlap, the 
unfolding can be considered thermodynamically reversible. This is commonly the 
case for lipid-free apolipoproteins. However, when there is a hysteresis, the 
unfolding is thermodynamically irreversible. This could result from kinetic effects in 
the unfolding or because the unfolded product is no longer the same as the starting 
state. A hysteresis is commonly seen in lipoproteins where heating leads to the 
protein dissociation and particle fusion (Gursky, Ranjana, & Gantz, 2002; Gursky, 
2015).  
 
2.3.2 Far-UV circular dichroism experiments 
 Far-UV CD data were recorded using an AVIV 400 spectropolarimeter. 
Spectra were recorded of 0.1 mg/ml SAA in standard buffer in a 1 mm cuvette from 




25°C. Final data were normalized to molar residue ellipticity (in units of 
deg·cm2·dmol-1) using the equation: 
[θ] = θ*Mo / (10*L*C) 
For SAA, θ (in mdeg) is the measured CD signal, mean residue weight, Mo=112.7 
Da, cell path length, L=0.1 cm, and protein concentration, C=0.1 mg/ml. The α-
helical content was then determined based on the measured molar residue 
ellipticity at 222 nm, [θ222], using the equation (Mao, 1984): 
% α-helix = (-[θ222] + 3,000) / 39,000 
Here [θ222] is the experimentally measured signal at 222 nm; this signal is assumed 
to be +3,000 for 100% random coil, and - 36,000 for 100% -helix.  
In far-UV CD thermal melts, CD signal at 222 nm was monitored during 
sample heating and cooling. The temperature was changed from 5°C to 65°C in 
1°C increments at a rate of either 60°C/hr or 10°C/hr. The Tm, which corresponds 
to the midpoint of the unfolding, was determined as the peak of the first derivative 
of the sigmoidal unfolding transition, d(222) / dT,  and was used to compare the 
stability of free and lipid-bound SAA. No scan rate effects were observed in the 
heating and cooling curves of either lipid-free or lipid-bound SAA, indicating that 
the unfolding does not involve high kinetic barriers (Jayaraman, 2015). 
 
2.4 Fluorescence spectroscopy 
 A protein’s intrinsic fluorescence results mainly from its aromatic residues, 




and 300 nm and re-emit it at longer wavelengths. Each residue differs in the 
wavelength of maximal absorbance, absorptivity and fluorescence quantum yield 
(Ghisaidoobe & Chung, 2014). Phe maximally absorbs at 257 nm and has a much 
lower absorptivity and fluorescence quantum yield than either Tyr or Trp; hence, 
Phe is a relatively weak fluorophore. The wavelength of maximal absorbance is 
274 nm for Tyr and 280 nm for Trp. The absorptivity of Trp is about 4 times that of 
Tyr leading to higher absorbance. The fluorescence quantum yield is also higher, 
0.20 for Trp versus 0.14 for Tyr. These differences in optical properties, along with 
the fluorescence energy transfer from Tyr to Trp, result in Trp being responsible 
for ~90% of the total intrinsic protein fluorescence upon excitation at 280 nm, which 
corresponds to an absorption maximum in proteins. (Teale & Weber, 1957; Sauer, 
Hofkens & Enderlein, 2011). 
To record protein fluorescence emission that originates from both Tyr and 
Trp, an excitation wavelength ex=280 nm is used. To record the emission from 
Trp alone, ex=295 nm is used. This is because only Trp and not Tyr shows 
significant absorption at 295 nm and, therefore, the Trp but not Tyr is excited. In 
the current study, we have obtained similar results by using both excitation 
wavelengths. The presented figures show data recorded using 295 nm. 
 Intrinsic fluorescence can provide information on the aromatic residue 
packing and any changes that occur as a result of protein folding, unfolding or 
ligand binding near these residues (Royer, 2006). This is because the wavelength 




(Konev, 1967 & Reshetnyak et al., 2001). A Trp buried in a hydrophobic 
environment has max = 315 - 330 nm, while a solvent-exposed Trp is characterized 
by max = 350 - 360 nm. Hence, a red shift in max reports on Trp becoming more 
solvent-exposed, while a blue shift reports on Trp burial upon protein folding or 
ligand binding.  
 mSAA1 has three Trp residues, W18, W29, and W53, located within helix 
1, the helix 1-2 linker, and helix 3, respectively. Internal fluorescence of these 
residues was recorded at different temperatures to monitor folding and unfolding 
of lipid-free SAA. Trp fluorescence spectra were also recorded at 25°C from free 
and lipid-bound SAA to determine whether these Trp residues are buried upon lipid 
binding.  
 Fluorescence was recorded using a Varian Cary Eclipse spectrofluorimeter. 
The emission spectra were monitored from 310 to 450 nm for 0.3 mg/ml SAA 
solutions using 280 nm or 295 nm excitation wavelengths. The excitation and 
emission slit widths were 5 nm. Spectra were taken in 5°C increments from 5°C to 
65°C. The wavelength of maximal fluorescence was determined by fitting the 
emission peak to a Boltzmann function.  
 
2.5 Negative-stain electron microscopy 
 Negative-stain transmission electron microscopy (EM) was used to 
visualize the SAA-containing lipoproteins.  SAA-POPC sample (4 µl) containing 




for 10 seconds. The drop was then removed and the sample was stained with 4 µl 
of 2% uranyl acetate for 10 seconds. The stain solution was removed and the grid 
was air-dried for 3 mins. The samples were viewed using a CM12 transmission 
electron microscope (Philips Electron Optics, Netherlands) equipped with Teitz 
2Kx2K CCD camera (TVIPS, Germany). EM data were collected with the 
assistance of Donald L. Gantz. 
 
2.6 Native (non-denaturing) gel electrophoresis 
 To determine the size of the SAA-containing lipoproteins prepared using 
either spontaneous reconstitution or cholate dialysis, non-denaturing 
polyacrylamide gel electrophoresis (PAGE) was employed. Novex™ 4-20% Tris-
glycine gels (Invitrogen) were loaded with 3-5 µg SAA per lane and run to 
completion at 50 V for 16-17 hrs using the Invitrogen XCell Surelock™ system. 
The gels were stained using EZ-Run protein gel staining solution (Fisher 
Bioreagents). The particle size was determined by comparison with the Stokes 
diameters of the globular proteins in the HMW Native Marker Kit (GE Healthcare 
Life Sciences): thyroglobulin (669,000 kDa; 17 nm), ferritin (440,000 kDa, 12.2 
nm), catalase (232,000 kDa, 10.4 nm), lactate dehydrogenase (140,000 kDa, 8.2 





2.7 Size-exclusion chromatography 
 Size-exclusion chromatography (SEC) was used to separate lipoproteins of 
various sizes formed after heating. 750 µl of ~3 mg/ml solution of 10:1 POPC:SAA 
sample from cholate dialysis before or after heating was injected into an AKTA 
UPC 10 FPLC system (GE Healthcare) and separated using a Superose 6 10/300 
GL column. The samples were eluted at a flow rate of 0.5 ml/min using 10 mM 
phosphate buffer, pH 7.5, with 150 mM NaCl. Collected fractions were pooled and 
concentrated for further analysis by CD, native PAGE and phospholipid analysis.    
 
2.8 Phospholipid analysis 
 Phospholipid analysis of SAA-containing lipoproteins was completed using 
an enzymatic Phospholipid C assay (FUJIFILM Wako Diagnostics). The kit 
promotes hydrolysis of phospholipids to produce choline that was further oxidized. 
Upon oxidation the solution turned blue and the absorbance at 600 nm was 
proportional to the phospholipid concentration. A serial dilution of the 300 mg/dl 
Phospholipid C standard solution was used to generate the standard curve.  
 Phospholipid C standard solution or the SAA-containing lipoproteins (2 µl) 
was added to a clear 96 well plate (Fisher). Color Reagent (300 µl) was added to 
each well, and the plate was incubated at 37°C for 5 mins. The absorbance at 600 






2.9 Hydrogen-deuterium exchange mass spectrometry 
2.9.1 Background 
Hydrogen deuterium exchange (HDX) mass spectrometry (MS) is a 
powerful tool to investigate protein folding, structure and dynamics of local regions. 
It leverages the fact that, since protein molecules in solution are dynamic, 
hydrogens associated with various protein groups are in continuous exchange with 
the solvent. In a typical aqueous buffer solution this would simply result in the 
replacement with a new hydrogen, which does not change any protein properties. 
By using a solution containing a hydrogen isotope, deuterium, the exchange of a 
hydrogen for a deuteron can be monitored over time to provide details about the 
packing of specific protein groups. Since the side chains show very fast exchange 
that is difficult to monitor in real time, HDX experiments typically monitor the much 
slower exchange of the backbone amide hydrogens, thereby providing information 
on the main chain conformation and dynamics (Wales & Engen, 2006 and 
references therein).  
 The hydrogen to deuterium exchange can occur at a wide range of rates, 
from seconds to many hours. The actual rate depends on four main factors: solvent 
accessibility, hydrogen bonding, pH and temperature. Since pH and temperature 
are controlled in HDX experiments, the differences in deuterium uptake can be 
attributed to solvent accessibility and hydrogen bonding. This allows us to 
differentiate between regions in the protein that are folded in solution and those 




will have a much slower rate of exchange than a loop or random coil. Additionally, 
a region of the protein that is involved in a binding interaction is expected to have 
increased protection from exchange as compared to the ligand-free state, making 
HDX MS useful for identifying certain ligand binding sites in proteins.  
 To detect differences in the rates of exchange within protein regions, 
varying deuterium labeling time points are compared. For labeling, the protein is 
added to an excess of heavy water, D2O, at pH 7.5 and is incubated for a specific 
time ranging from seconds to hours. At this pH, fully solvent-exposed peptides 
exchange rapidly with rates 10-1,000 s-1 (Bai et al., 1993, Marcsisin & Engen, 
2010). After incubation, the reaction is quenched to stop the exchange, ensuring 
that the deuterium that has been taken up by the protein is still present during the 
analysis. To quench the reaction, the pH of the solution is lowered to 2.5 and the 
temperature is decreased to 0°C. These quenching conditions decrease the rate 
of amide exchange by about five orders of magnitude (Marcsisin & Engen, 2010 & 
references therein).  
 MS is employed to measure the mass of the protein fragments and thereby 
to analyze the uptake of deuterium in different protein regions corresponding to 
these fragments. The protein is enzymatically digested using pepsin, which is 
active at pH 2.5, and the mass of the resulting peptides is determined using liquid 
chromatography mass spectrometry (LC-MS). The mass of each peptic fragment, 
which increases with increased Deuterium uptake, is compared to that of an 




 Using MS to monitor the exchange lowers the resolution compared to 
nuclear magnetic resonance (NMR) spectroscopy, another method commonly 
used in hydrogen exchange experiments. As opposed to NMR, which monitors the 
hydrogen-deuterium exchange at the single amino acid resolution, MS is limited in 
resolution by the length of peptic peptides and by their overlap. To overcome this 
limitation, it is important to obtain high overall peptide coverage and high 
redundancy (i.e. overlap among different peptides). With high redundancy the 
uptake can be better localized, though methods to increase the resolution to the 
levels of NMR are still being developed and are not currently available. Even 
though MS does not offer the single-residue resolution achievable by NMR, it is 
still preferred for our system. The limited solubility of SAA as well as the 
heterogeneity of the SAA-POPC complexes preclude the use of NMR to monitor 
the exchange. An advantage of HDX MS is that, unlike NMR, it does not require 
expression of a protein labeled with heavy isotopes. 
 
2.9.2 HDX mass spectrometry experiments of the current study 
 Far-UV CD enables us to determine the overall secondary structure of SAA 
either in solution or on the lipid. However, far-UV CD does not provide any 
information about the location of the α-helices in the protein.  HDX MS was 
employed to gain insight into the local structure of SAA in solution and on the lipid, 
and to compare the local structural protection in free SAA and in SAA-POPC 




comparison enabled us to identify protein segments that undergo lipid-induced 
conformational changes.  
 To label, SAA solutions (containing either free SAA or 1:10 SAA:POPC) at 
a protein concentration of 0.5 mg/ml in standard buffer were used. Continuous 
labeling experiments were initiated with an 18-fold dilution into D2O buffer (10 mM 
phosphate, pD 7.5) at 5°C. Limited studies were also carried out at 15°C and 25°C. 
The labeling proceeded for the predetermined time between 5 s and 4 hrs, 
whereupon the reaction was quenched with a 2x dilution with quench buffer (150 
mM sodium phosphate, pH 2.3, H2O) at 0°C and moved to 0°C. SAA was 
immediately digested with a pepsin solution (10 mg/ml pepsin in H2O) for 5 min 
using a 1:20 mg:mg protein:enzyme ratio. The digested protein (~45 pmol) was 
injected into a Waters NanoAcquity UPLC with HDX technology, and peptides 
were separated on a Waters BEH C18 analytical column during a 6 min, 5-35% 
water-acetonitrile gradient. Peptide masses were determined using a SnyaptG2Si 
QToF mass spectrometer by Waters equipped with an ESI source. Each peptide 
was identified using a combination of exact mass measurement and MSE by 
ProteinLynx Global Server 3.0 software (Waters) and levels of deuterium uptake 






Figure 2.3 HDX MS Workflow.  
SAA, either lipid-free or in complex with POPC, was placed in a solution of heavy 
water (D2O) for the predetermined reaction time. The reaction was then quenched 
and the protein proteolyzed. MS detected the mass of each fragment, thereby 
monitoring the relative uptake of deuterium. Adapted with modifications from 






2.10 Limited proteolysis 
 Limited proteolysis was used to compare the accessibility of free SAA and 
lipid-bound SAA to trypsin. This method provides an additional approach for 
probing the protein structure and flexibility: well-folded lipid-bound proteins are 
expected to be cleaved at a slower rate than less well-folded free proteins. In our 
studies, trypsin digestion of lipid-free and lipid-bound SAA was compared to 
identify the regions that become protected when bound to the lipid.  
 SAA (0.5 mg/ml) with or without lipid was incubated with trypsin at a 200:1 
weight ratio of SAA to trypsin for varying amounts of time at 25°C. The reaction 
was quenched by the addition of 2x SDS loading buffer (G Biosciences) and boiled 
for 5 mins. The sample was run on an 18% Tris-Glycine gel (Invitrogen) at 80 V for 
10 mins and then at 200 V for 1 hr in an Invitrogen XCell Surelock™ system. The 




CHAPTER THREE: Amino Acid Sequence Analysis and X-Ray Crystal 
Structures Suggest a Novel Lipid Binding Site in SAA 
 
3.1 Introduction 
  Most SAA circulates in plasma bound to high-density lipoproteins (HDL) 
(Benditt & Eriksen, 1977, Coetzee et al. 1986, Kisilevsky & Manley, 2012). 
However, the mechanism by which SAA binds to lipids remains unclear. Studies 
to establish the lipid-binding site of SAA identified the role of the N-terminal region, 
in particular residues 1-11, in lipid binding (Patel et al. 1996, Liang et al. 1996, 
Ohta et al. 2009 & others). These studies relied on the use of antibody competition 
assays or the use of SAA fragments; however, no direct binding studies using full-
length SAA have been reported. To complicate the matter, structural details of SAA 
were limited to the use of indirect approaches and prediction algorithms until three 
crystal structures of human SAA1 (hSAA1) and murine SAA3 (mSAA3) were 
solved in 2014 to 2.2Å resolution (Lu et al. 2014, Derebe et al. 2014) (see 
Introduction for details).  
The hexamer, which was captured in one of the three SAA crystal 
structures, was proposed to bind to HDL (Lu et al. 2014).  A charged triad located 
at the apex of the SAA hexamer containing residues Arg1, Arg62 and His71, was 
suggested as a potential HDL binding site due to the role of these charged residues 
in heparan-sulfate binding, which interferes with HDL binding (Lu et al. 2014). 
Additionally, mutating each of these residues to an alanine interrupted SAA binding 




changes that are not limited to the mutation site; therefore, these results do not 
necessarily indicate that the mutated resides are directly involved in HDL binding. 
Moreover, we find flaws with this model of SAA-HDL binding: (a) the SAA hexamer 
lacks a large contiguous apolar surface that is prerequisite for HDL binding; (b) the 
HDL surface is comprised of mainly uncharged lipids, phosphatidylcholine (PC) 
and cholesterol, while the proposed binding site on the hexamer is charged 
(Christinat & Masoodi, 2017); (c) the proposed triad does not explain the binding 
preference of SAA to HDL over larger more electronegative lipoproteins; (d) cross-
linking studies have shown that the hexamer must dissociate into monomers to 
bind to HDL (Wang & Colon, 2004). Additionally, this proposed binding site does 
not agree with the previous lipid binding studies that have implicated the N-terminal 
residues in binding to both cholesterol (Liang et al. 1996) and egg PC (Ohta et al. 
2009). Therefore, we decided to re-evaluate the HDL binding site in SAA. Even 
though the crystal structures of SAA are of the lipid-free state, they can still provide 
valuable insights into the lipid-bound protein conformation and the nature of the 
protein-lipid interactions.  
In this chapter, we have combined the sequence analysis of 19 SAA 
proteins, including different isoforms of SAA from different species, from humans 
to sea cucumbers, with detailed analysis of the three structures determined by x-
ray crystallography. The results have allowed us to propose a novel lipid-binding 
site in SAA that can explain the binding preference of SAA for HDL over larger, 




3.2 Sequence conservation in the SAA protein family 
 To investigate the evolutionary conservation of SAA, we aligned 19 
sequences of different SAA orthologues and isoforms (Table 2.2). The amino acid 
sequences ranged from 103 to 112 residues in length. The results are summarized 
in the conservation plot (Fig. 3.1). The height and brightness at specific locations 
in the plot indicate the level of conservation. The most conserved regions of SAA 
correspond to residues 30-65 of hSAA1. In most cases, this conservation is strict 
through evolution, which is highlighted by a large number of single amino acids in 
the consensus sequence.  In fact, the sea cucumber and the human protein, which 
represent the largest difference in organismal order, share 75% sequence 
similarity and a 66% sequence identity (Stothard, 2000).  
The differences in protein lengths are a result of a short insert either at the 
N-terminus, as seen in the chicken and wallaby sequences, or in the h3-h4 linker 
between residues 68 and 69 of the hSAA1, as seen in the cow, horse, sheep, cat, 
cheetah, dog and mink sequences. The occupancy plot highlights these insertions 
with the dark gray peaks between the lighter gray rectangles (Fig. 3.1). Our 
sequence alignment is in agreement with previously constructed plots (Uhlar, 
1994, Kisilevsky & Manley, 2012, Lu et al. 2014). One especially important 
similarity is strict conservation in the h2-h3 stretch, specifically in residues 33-63, 
which were found to have 87% homology between humans, mice, rabbits, cats, 
ducks, fish, and echinoderms (Kisilevsky & Manley, 2012). Overall, the high 







Figure 3.1 Amino acid sequence conservation in the SAA protein family. 
Sequence alignment performed using the Clustal Omega Server (Sievers et al. 2011). Acidic (purple), basic (red), 
Gly (pink), polar and apolar (green to blue) amino acids are color-coded using Clustal color scheme; amino acids 
that are not conserved are not colored. Residue numbers correspond to hSAA1 and schematic displays secondary 




structures of hSAA1 and mSAA3 monomers, strongly suggests that the structure 
of the SAA monomer has been preserved through evolution.  
 
3.3 Secondary structural propensities of SAA are consistent with the crystal 
structures 
  Next, we analyzed the α-helical propensity of these 19 SAA sequences. 
Previous sequence analysis predicted that SAA was mainly α-helical, up to 80% 
helix, with the remaining structure being unordered (Stevens, 2004). In our 
analysis, all 19 sequences of SAA have a helical profile that matches that seen in 
the crystal structures (Fig. 3.2). The well-defined peaks with α-helical propensity 
greater than 1 represent residues 5-30, 55-65 and 75-85, which correspond to h1, 
h3 and h4 in the crystal structure, respectively. Unordered loops are predicted 
before and after h3 and h4, the latter representing the unstructured C-terminal tail 
depicted by the schematic shown in Fig. 3.2 above.  Overall, our sequence 
analysis of α-helical propensity agrees with the crystal structures and with previous 
sequence analysis (Stevens, 2004). The high similarity between the α-helical 
propensities of different SAA proteins further supports the premise that the 4-helix 
bundle of SAA is evolutionarily conserved. Surprisingly, h4 consistently showed 







Figure 3.2 Propensity for α-helix of SAA proteins. 
The α-helical propensities of the 19 SAA sequences were obtained using the Levitt 
scale on the ExPasy server (Walker, 2005).  Residue numbering follows hSAA1; 
additional residues that are present at the N-terminal end or in the h3-h4 linker of 
other proteins are not shown. Schematics above the plot depicts helices h1-h4 and 
h’ (rectangles) and linkers (lines) observed in the crystal structures. Figure adapted 





3.4 Hydrophobicity profiles of SAA family members 
 Since lipoproteins, including HDL, have a near-zero net charge, binding 
interactions among exchangeable apolipoproteins and the phospholipid monolayer 
on the lipoprotein surface are facilitated mainly by the apolar faces of the 
amphipathic apolipoprotein α-helices that embed into the lipid monolayer (Segrest 
et al. 1992). To identify such amphipathic helices in SAA, we used the Kyte-
Doolittle hydrophobicity scale to analyze 19 SAA sequences. The results are 
presented in Fig. 3.3A with the labeled amino acids corresponding to hSAA1. 
 Hydrophobicity profiles of all proteins showed a local maximum at residues 
50-56 often followed by a smaller peak near residue 68 (Fig. 3.3A). These peaks 
delineated the N-terminal and C-terminal ends of the highly conserved h3 that 
showed high hydrophobicity in all proteins. In addition, several SAA proteins 
(human SAA1 and SAA2, mouse SAA1, cat SAA1) showed the major 
hydrophobicity maximum near the N-terminal end of h1 (Fig. 3.3A, top panel). This 
is not surprising since residues 1-11 in hSAA have been implicated strongly to form 
the major HDL binding site and to contain the major amyloidogenic segment 2-9 
(Colon et al. 2015, Das & Gursky, 2015). In contrast, in other proteins such as 
human SAA4, mouse SAA3, rat SAA, and trout SAA, the N-terminal end of h1 was 
substantially charged or polar (Fig. 3.3A, bottom panel), suggesting reduced 
affinity for HDL. Consistent with this analysis, in acute phase in rat and trout, the 
levels of circulating HDL-bound SAA do not increase, and only local increase in 






Figure 3.3 Hydrophobicity profiles of SAA proteins. 
A.) Kyte-Doolittle hydrophobicity profiles of SAA sequences obtained by using 
ExPASy server. Residue numbering follows hSAA1; extra residues present at the 
N-terminal end or the h3-h4 linker of other proteins are not shown. 
B.) Helix wheel diagrams of hSAA1.1 constructed according to (Armstrong & 
Zidovetzki). Circles representing apolar (gray) and polar residues (white) are color 
coded. Acidic (red letters) and basic (blue letters) residues are colored. The 
hydrophobic moment, µ, is right to left; µ(h1) = 11.9 and µ(h3)= 6.7, while h2 and 




Rossman et al, 2014, Villarroel et al, 2008). In summary, h3 in all species and h1 
in some species have high hydrophobicity, while the rest of the SAA molecule is 
relatively polar. 
Helix wheel diagrams of all SAA proteins revealed that h1 and h3 can form 
amphipathic α-helices with large relatively straight apolar faces (Fig. 3.3B). Similar 
helices form the major lipid surface-binding motif in apolipoproteins (Segrest et al. 
1992). In all SAA proteins, h1 exhibited the highest hydrophobic moment (µ=8–12) 
followed by h3 (µ=5–8), while h2 and h4 consistently showed low hydrophobic 
moments (µ=0–3) (Fig. 3.3B). Interestingly, the hydrophobic moment of h1 was the 
highest even in sequences where the hydrophobicity profiles did not show a peak 
at the N-terminal. The high hydrophobic moment of h1 in all sequences suggests 
that even in sequences that do not have high hydrophobicity in the N-terminal 
region, hydrophobic residues are located predominantly on the same face of h1.  
Importantly, h1 and h3 are located on the same side of the SAA monomer 
in the crystal structures. This suggests that the lipid surface binding site in SAA is 
located in h1 and h3, and not just in the N-terminal end of h1 as previously thought. 
Experimental evidence for this is presented in Chapter 5. 
 
3.5 Transmembrane propensities of SAA family members 
 To determine if h1 and h3 have the ability to embed into a lipid bilayer, we 
analyzed transmembrane propensities for seven SAA sequences (Fig. 3.4). The 





Figure 3.4 Profiles showing transmembrane potential of SAA proteins. 
The profiles of selected SAA proteins were obtained using Zhao & London scale 
for transmembrane potential. Schematic of the h1-h4 helices and loops/turns 






their hydrophobicity profiles, with the most hydrophobic segments, h1 and h3, 
having higher probability to form transmembrane helices.  
Of the seven SAA sequences analyzed, rat SAA showed the lowest 
transmembrane potential in the N-terminal end, suggesting that this protein has 
reduced HDL-binding propensity. This finding may help explain why rat SAA does 
not bind HDL during acute inflammation (Baltz et al. 1987, Meek & Benditt, 1989).  
The transmembrane propensity of h1 in all seven SAA sequences 
decreased from the N-terminus to the C-terminus; this trend was most pronounced 
in human SAA1 and SAA2, mouse SAA1, and rabbit SAA1. This finding suggests 
that h1 potentially enters the lipid monolayer at an angle, so the N-terminal end is 
embedded in the lipid and is in contact with the fatty acid chains, while the C-
terminal end of h1 sits on the surface.  
In summary, the hydrophobicity and the transmembrane profiles of the SAA 
sequences strongly support the notion that h1 and h3 are lipophilic.  
 
3.6 Surface hydrophobicity suggests a novel HDL binding site in SAA 
monomer 
 To determine whether h1 and h3 form a contiguous hydrophobic surface in 
the 3D structure of SAA, we mapped the hydrophobicity characteristics onto the x-
ray crystal structure of the SAA monomer. The following discussion focuses on a 




SAA monomer from the other two crystal structures of hSAA1 and mSAA3 (PDB 
ID 4IP9 and 4Q5G, respectively) indicate similar properties.  
 The surface hydrophobicity reveals an elongated concave hydrophobic 
surface formed by h1 and h3 (Fig. 3.5). This hydrophobic surface is estimated to 
be 40Å x 10Å in size, and the radius of curvature of this surface is approximately 
4.2 nm.  Notably, this curvature of SAA complements HDL curvature (r = 4-6 nm). 
This makes it immediately clear how the SAA monomer can bind to HDL via this 
solvent-exposed hydrophobic site. Moreover, HDL binding at this site explains the 
preferential binding of SAA to HDL over larger less curved lipoproteins, LDL (r=10-
12 nm) and VLDL (r=10-50 nm).  
 Similar to hSAA1 monomer, mSAA3 monomer shows an elongated 
concave hydrophobic surface formed by h1 and h3 (Fig. 3.6). The main differences 
are in h1 where mSAA3 is less hydrophobic (Fig. 3.5 vs. Fig. 3.6). This is in 
agreement with the hydrophobicity plot of mSAA3, which is one of the sequences 
that lacks a large hydrophobic peak in h1. Still, h1 and h3 in mSAA3 form a 
contiguous hydrophobic surface whose curvature complements HDL. This is in 
agreement with recent reports indicating that, despite reduced N-terminal 






Figure 3.5 Surface hydrophobicity of hSAA1. 
Space-filling model of hSAA1 monomer (PDB ID: 4IP8) colored according to 
hydrophobicity. Apolar groups are in gold and polar in gray. The two views 
differing by 60° highlight the large concave apolar surface comprised of h1 and 
h3. * indicates amyloidogenic segments predicted in residues 2-9, 53-55 and 67-







Figure 3.6 Surface hydrophobicity of mSAA3. 
Space-filling model of mSAA3 monomer (PDB ID: 4Q5G) colored according to 
hydrophobicity. Apolar groups are in gold and polar in gray. The two views differing 
by 60° highlight the curved apolar surface comprised of h1 and h3. Figure adapted 





3.7 Relevance to SAA amyloid formation and self-association 
Lipid binding via SAA helices h1 and h3 provides a structural basis to 
explain how HDL binding protects SAA from forming amyloid at pH 7.5 (Jayaraman 
et al., 2017). Protein misfolding, from a native conformation into an intermolecular 
cross-β-sheet in amyloid, is thought to be initiated by short adhesive 6-10 residue 
segments that are usually hydrophobic (Das & Gursky 2015 and references 
therein). SAA contains three such amyloidogenic segments that were predicted in 
h1 and h3 (Patel et al. 1996, Egashira et al. 2011, Das & Gursky, 2015). These 
segments are located at the ends (residues 2-9 and 67-70) or in the middle (53-
55) of the hydrophobic surface that, we propose, binds HDL (Fig. 3.5). In the lipid-
free SAA monomer these segments are solvent exposed, which can facilitate their 
adhesion to similar segments from other SAA molecules and promote their 
misfolding and aggregation. However, if SAA binds HDL via h1 and h3, these 
amyloidogenic segments become protected from misfolding by the protein-lipid 
interactions.  
Additionally, solvent exposure of the large continuous apolar face in SAA 
monomer is expected to be energetically unfavorable. Therefore, in the absence 
of HDL or other apolar ligands, SAA helices h1 and h3 are expected to either be 
partially unfolded and/or to be involved in protein self-association. In fact, free SAA 
is self-associated in solution apparently via h1 (Colon et al. 2015, Jayaraman et al. 





3.8 GPGG motif helps confer surface curvature to the HDL binding site  
Our results suggest that SAA binds to HDL through the concave apolar surface 
formed by h1 and h3, which explains two important experimental observations: the 
preference of SAA for binding to HDL over larger lipoproteins, LDL and VLDL (Benditt 
& Eriksen, 1977, Coetzee et al. 1986), and the protective effect of HDL binding on the 
amyloid formation by SAA at pH~7 (Claus et al. 2017; Jayaraman et al.2017). This 
suggests that the curved apolar surface formed by h1 and h3 is important both for 
normal functions of SAA in lipid transport and for its pathologic misfolding in amyloid. 
Therefore, we aimed to identify the structural determinants for this helical packing in 
SAA.  
The curvature of the apolar surface formed by h1 and h3 is defined by the ~43 
angle between these helices (Figs. 3.5, 3.6). Analysis of the x-ray crystal structures 
suggests that this angle is critically hinged upon the h2-h3 linker containing the strictly 
conserved GPGG motif (Fig. 3.7A). In all SAA molecules from the three available 
crystal structures, this well-ordered motif forms a tight turn that enables a close 
packing of h3 against h1 (Fig. 3.7B). G50, G51, A54, and A55 from h3 pack against 
A10 and G13 from h1, locking h1 in a groove formed by the GPGG motif at the N-
terminal end of h3 and facilitating an unusually close spacing between these helices 
(Fig. 3.7A). This spacing is characterized by only 3.6 Å separation between the main 
chain atoms Cα of A10 and C of G50 and between N of A10 and C of G50. The small 






Figure 3.7 A unique GPGG motif in SAA facilitates h1 and h3 packing at a 43° 
angle, which defines the curvature of the apolar face. 
A.) Ribbon diagram showing the GPGG motif in the crystal structure of hSAA1. 
Gly (blue), Pro (orange) and Ala (green) involved in tight helical packing are 
color-coded. Arrows depict helical direction from the N- to the C-terminus. 
Black line represents 3.6Å main chain separation between A10 and G50. 
B.) Amino acid alignment shows that the residues which facilitate unusually tight 
packing of h1 against h3 are 100% conserved: G48, P49, G50, G51, along 





likely critical for such close main chain separation, while the proline is crucial for the 
sharp turn in the linker that facilitates h3 packing against h1 and h2.  
Notably, the residues critical for the packing of h1 against h3, including A10, G13, 
G48, P49, G50, G51, A54 and A55, are strictly conserved (Fig. 3.7B), suggesting that 
the angle between h1 and h3 (and hence, the curvature of the proposed lipid-binding 
surface) is also conserved throughout evolution. We propose that the GPGG motif 
and other conserved residues involved in h1-h3 packing determine the curvature of 
the apolar surface in SAA and hence, its binding preference for HDL-size lipoproteins.  
 
3.9 The relationship between the crystal structures and the solution 
conformations of lipid-free and lipid-bound SAA  
The crystal structures of lipid-free SAA have ~70-80% α-helix, which 
represents the maximally folded protein conformation. In fact, CD spectra of free SAA 
in solution in the presence of a protein folding osmolyte, trimethylamine N-oxide 
(TMAO), also show ~70-80% α-helix content (Jayaraman, unpublished data). An 
important question is how the maximally folded SAA conformation seen in the crystal 
structure or in TMAO relates to the protein conformation free in solution and on 
lipoproteins. Like other intrinsically disordered proteins (Dyson & Wright, 2005; Wright 
& Dyson, 2009; Arai 2018), free SAA is unfolded in solution in the absence of bound 
ligands at physiological conditions and can fold upon ligand binding. Lipid binding 
induces helical folding in SAA, and lipid-bound SAA obtains ~45% α-helical content 




et al. 2014, Jayaraman et al. 2015) and POPC (Jayaraman et al. 2015, Frame et al. 
2017). Therefore, the experimental data together with our bioinformatics analyses 
suggested that h1 and h3, undergo α-helical folding as they bind to the lipid, while h2 
and h4 likely remain largely unfolded. This hypothesis is refined in our hydrogen-
deuterium exchange studies described in Chapter 5 below.  
  
3.10 Surface properties of helices h2 and h4 suggest their possible ligands  
 In contrast to h1 and h3, SAA helices h2 and h4 lack large apolar faces (Fig. 
3.2) and are unlikely to directly bind to lipid surface. This observation is consistent 
with the SAA crystal structures wherein h2 is packed against h1 and h3 opposite 
to the proposed HDL binding site. Therefore, in lipid-bound SAA, h1 and h3 are 
expected to be sandwiched between h2 and lipids and partially retain their 
conformation seen in the crystal structures, particularly the packing of h1 against 
h3 via the GPGG motif (Fig. 3.4). This idea is substantiated in H-D exchange 
studies described in Chapter 5. Together, these results suggest that unlike other 
apolipoproteins, such as apoA-I, the 4-helix bundle of SAA does not open into two 
helical pairs on the lipid surface. Rather, SAA oligomers dissociate to expose the 
curved apolar surface in the monomer that binds to HDL via h1 and h3; the 
conformation of these helices resembles that seen in the crystal structures of lipid-
free proteins. This lipid binding mode is unique to SAA and differs from the helix 
bundle opening into two pairs of antiparallel helices, h1-h2 and h3-h4, which was 




 The electrostatic surface potential mapped on the SAA crystal structure 
further supports the idea that h2 and h4 do not directly bind HDL and suggest other 
functional ligands for these helices. The molecular face formed by h2 and h4, which 
is opposite to the hydrophobic face formed by h1 and h3, has a large acidic patch 
formed by aspartic and glutamic acids (Glu74, Asp75, Glu84, Asp91) in h4, (Fig. 
3.8). This electronegative patch is likely to bind to electropositive partners, rather 
than to the HDL surface. Such likely partners have emerged from previous studies 
by other groups that identified ligands that bind to h4 and the C-terminal tail of 
SAA. One of these ligands is the cell receptor CD36, which binds either free or 
HDL-bound SAA (Baranova et al. 2005, Baranova et al. 2010). CD36 and another 
scavenger receptor, SR-BI, both bind anionic phospholipids (Rigotti et al. 1995, 
Ryeom et al. 1996). Additionally, a homology model of the CD36 ectodomain 
suggested that ligands bind at the basic apex of the helix bundle in these receptors 
(Jimenez-Dalmaroni et al. 2009). Other cell receptors that bind SAA, such as LOX-
1 and RAGE, also rely on electrostatic interactions to bind ligands. Specifically, the 
basic residues in the loop of the lectin-like domain of LOX-1 were required to bind 
to oxidized LDL (Chen et al. 2001). Further, the basic apex of RAGE has also been 
implicated to bind to many ligands (Koch et al. 2010, Fritz, 2011). Taken together 
with our analysis, these findings compel us to propose that the acidic patch on the 
SAA surface, which is comprised of h4 and h2, forms the binding site for several 






Figure 3.8 Surface electrostatic potential distribution of hSAA1.  
Space-filling model of hSAA1 monomer (PDB: 4IP8) colored according to charge: 
acidic (red), basic (blue). Left: Side view showing a surface formed by h2 and h4. 





3.11 Comparison of hSAA1 with mSAA1 
 High surface hydrophobicity of SAA and its IDP character lead to its high 
aggregation propensity, presenting a challenge for protein expression, purification 
and biophysical studies.  Reduced aggregation propensity of the N-terminal region 
compared to hSAA1 leads to higher solubility of the murine protein. For this reason, 
in our experiments we used recombinant mSAA1. Both mSAA1 and hSAA1 are 
major isoforms that bind HDL and form amyloid in vivo. The amino acid sequence 
of mSAA1 is very similar to that of hSAA1, with 81% similarity and 73% identity 
(Stothard, 2010). Since the atomic structure of mSAA1 is not available, we used 
Swiss-Model software to generate a homology model of mSAA1 based on the 
crystal structure of hSAA1 (Waterhouse et al. 2018, Bienert et al. 2017, Guex et 
al. 2009, Benkert et al. 2011, Bertoni et al. 2017). The space-filling model of 
mSAA1 shown in Figure 3.9 is colored according to surface hydrophobicity as 
described for the hSAA1 and mSAA3 structures. The mSAA1 homology model 
presents the same curved hydrophobic face as the crystal structures of hSAA1 and 
mSAA3, but with slightly reduced hydrophobicity at the C-terminal end of h1. 
Furthermore, like in hSAA1, h2 and h4 in mSAA1 lack a hydrophobic surface. This 
model suggests strongly that mSAA1 will bind to lipids via the similar site as 






Figure 3.9 Surface hydrophobicity of mSAA1.1.  
Space-filling model of mSAA1.1 monomer was generated using Swiss-Model 
software based on the atomic x-ray crystal structure of hSAA1. Surface is colored 
according to hydrophobicity: apolar – gold, polar - gray. Two views show the 
monomer in two orientations that differ by a 60° rotation. Dashed arc indicates 






3.12 Proposed lipid-binding site in SAA 
 Sequence analysis of SAA family members combined with the 
reassessment of the available crystal structures has allowed us to propose a novel 
HDL binding site in SAA. Hydrophobicity maxima in SAA correspond to the two α-
helices, h1 and h3, seen in the crystal structure. These amphipathic helices exhibit 
all the properties of lipid-binding domains found in other apolipoproteins. Moreover, 
in the crystal structures of SAA, h1 and h3 form a large exposed concave 
hydrophobic surface. This surface has a radius of curvature of 4.2 nm, which is 
commensurate to that of HDL. SAA binding to HDL likely occurs through this face, 
instead of the typical opening of the helix bundle seen in other apolipoproteins 
such as apoA-I and apoE. Furthermore, by binding to HDL via this site, SAA will 
protect its amyloidogenic segments, which helps explain the experimental 
observations by us and our collaborators that HDL binding protects SAA from 
forming amyloid (Claus et al. 2017, Jayaraman 2017). Lastly, the curvature of the 
proposed HDL binding site in SAA seems to be a result of a unique motif of 
glycines, alanines, and a proline facilitating an unusually tight packing of h3 against 
h1. In particular, a unique GPGG motif causes a tight turn in the h2-h3 linker 
leading to an unusually close main chain separation between h1 and h3 of only 
3.6Å. The GPGG motif and other Ala and Gly residues involved in h1/h3 packing 
are strictly conserved through evolution, suggesting that the curvature of the apolar 
face in SAA monomer has also been conserved. To our knowledge, the GPGG 




curved apolar face formed by these helices are unique to SAA and have not been 





CHAPTER FOUR: Structure and Stability of Model SAA-containing 
Lipoproteins 
4.1 Introduction  
 Upon secretion of SAA by the liver during the acute-phase response, SAA 
binds to preformed HDL that circulate in plasma. This binding alters the protein 
and lipid composition of HDL (Coetzee et al. 1996, Abe-Dohmae et al. 2006, 
Kisilevsky & Manley 2012, Ye & Sun 2015, Perrone et al. 2008); in some instances, 
SAA-only HDL are formed (Cabana et al. 1999). Not only can SAA bind to pre-
existing HDL but it can form lipoproteins de novo. The de novo formation can be 
facilitated by the ABC transporters (Stonik et al. 2004, van der Westhuyzen et al. 
2005, Abe-Dohmae et al. 2006, Hu et al. 2008, de Beer et al. 2011), but they are 
not required (Stonik et al. 2004). The ability of SAA to bind to preexisting HDL or 
form HDL-sized particles de novo suggests a common mechanism for lipid binding. 
This mechanism was explored in the current chapter by using complexes 
reconstituted from SAA and model lipids. To test our hypothesis that SAA helices 
h1 and h3 bind to lipids, an in vitro system of SAA-only lipoproteins, which were 
formed in a transporter independent manner, was developed. In this study, the 
structure, stability, and thermal remodeling of SAA-only complexes with lipid 
constituents of the plasma membrane was explored. For the majority of the work, 
we used binary complexes containing various amounts of SAA and POPC, a 




cell membranes. In addition, ternary complexes of SAA, POPC, and cholesterol, 
and quaternary complexes of SAA, POPC, POPG, and PS were also explored. 
Previously, our laboratory showed that all major lipoprotein classes are 
stabilized by high kinetic barriers, and thermal remodeling mimics important 
aspects of their metabolic remodeling by plasma factors (Gursky, 2015 and 
references therein). In fact, both thermal and metabolic remodeling of HDL 
involves protein release in a lipid-poor form and fusion of protein-depleted 
lipoproteins into larger particles; such fusion alleviates the imbalance between the 
polar surface of a lipoprotein and its apolar interior (Jayaraman et al., 2006). 
Therefore, thermal remodeling provides a useful tool to explore structural stability 
of lipoproteins and their morphologic transformations that mimic their functional 
remodeling in vivo. This tool was used in the current chapter to explore stability 
and remodeling of various SAA-lipid complexes. 
 
4.2 SAA-containing lipoproteins formed by spontaneous reconstitution  
4.2.1 SAA-POPC complexes formed at various protein:lipid ratios  
 To explore the lipid-bound conformation of SAA, we used SAA-only 
lipoproteins in vitro. These lipoproteins were formed through spontaneous 
reconstitution with POPC small unilamellar vesicles (SUV), which were formed by 
sonication. SAA and POPC SUV were incubated at room temperature at different 




lipid particles, the mixtures were separated by native PAGE to assess the 
migration of SAA, which was compared to the migration of free SAA that runs as 
an oligomer with a hydrodynamic size of approximately 7.3 nm (Fig. 4.1). Upon the 
addition of small amounts of POPC, corresponding to protein:lipid molar ratios of 
1:0.5 to 1:2, a second band became apparent on the gel. This band ran between 
7.6-8.3 nm and increased in intensity at a higher lipid content. At 1:5 protein:lipid, 
the amount of free protein abruptly decreased while the hydrodynamic size in the 
new band slightly increased to about 8.5-10 nm; this particle size remained 
invariant upon further addition of lipid (Fig. 4.1, gel). At 1:20 ratio another band 
was observed corresponding to particle sizes over 20 nm that remained at higher 
lipid ratios.  
 The particles formed through spontaneous reconstitution were visualized 
using negative stain EM. Free SAA was not clearly seen by EM; instead, it formed 
a continuous background on the EM grid (Fig. 4.1, bottom panel). In SAA:POPC 
preparations containing 1:5 and 1:10 protein:lipid, particles of 8-10 nm were 
observed. The particles were evenly spaced on the grid and heterogeneous in 
shape (Fig. 4.1, center panel). The lack of vesicles observed at these protein:lipid 
ratios indicated that all lipid was incorporated into the small SAA complexes. At 
higher amounts of lipids, 1:20 and 1:80 SAA:POPC, larger vesicles were seen in 
addition to the 8-10 nm particles (Fig. 4.1, top panel). Therefore, the presence of 
the additional band at the top on the native gel for these samples represented SAA 





Figure 4.1 SAA-POPC complexes formed by spontaneous reconstitution.  
Non-denaturing gel electrophoresis and corresponding negative stain electron 
micrographs of SAA-POPC complexes formed using SAA:POPC molar ratios 
ranging from 1:0.5 to 1:80. Lipid-free SAA is shown as a comparison. Figure 





4.2.2 Structure and stability of SAA-POPC mixtures  
We next explored the structure and stability of the various SAA-POPC 
complexes. Previous studies showed that lipid-free SAA is partially folded at 5°C 
but unfolds with a midpoint, Tm ~ 17°C, and is largely unfolded at room temperature 
(Takase et. al, 2014 & Jayaraman, 2015). Therefore, in our next studies the 
secondary structure was monitored by far-UV CD at both 5°C and 25°C.  
At 5°C lipid-free SAA was ~25% α-helical while at 25°C it displayed a 
random coil signature in the far-UV CD spectrum (Fig. 4.2A, black). POPC led to 
lipid-induced α-helical folding of SAA, indicated by an increase in the negative CD 
signal at 208 nm and 222 nm. At 25°C a clear progression in protein folding, from 
the largely unstructured to a highly -helical conformation was observed at 
increasing lipid concentrations (Fig. 4.2A). Adding lipid up to 1:5 SAA:POPC 
caused the greatest increase in the helical structure (Fig. 4.2A, green to blue), with 
little changes observed upon further addition  of lipid (Fig. 4.2A. purple to red). A 
similar lipid-induced trend was observed at 5 °C as illustrated in Figure 4.2B 
showing the -helical content as a function of protein:lipid ratio determined from 
the CD spectra at 5 °C (grey) and at 25°C (black). The maximal α-helical content 
of SAA was ~48%, which was observed at both temperatures.  
Next, the structural stability of SAA-POPC complexes was explored. 
Incubation mixtures containing various protein:lipid ratios were heated and cooled 
at a constant rate of 60°C/h, and helical unfolding and refolding was monitored as 





Figure 4.2 Secondary structure of SAA-POPC complexes formed by 
spontaneous reconstitution. 
A) Far-UV spectra at 25C for complexes formed using SAA:POPC molar ratios 
ranging from 1:0.5 to 1:80. Spectra are colored from green (least amount of 
lipid) to red (most lipid). Lipid-free SAA is shown as a comparison (black).  
B) Helical content of SAA determined by far-UV CD at 5C (gray) and 25C (black) 
is plotted as a function of the protein:lipid molar ratio.  





reversible unfolding with a transition midpoint Tm=17°C (Fig. 4.3A, black), while 
lipid-bound SAA had its thermal unfolding shifted to much higher temperatures, 
with an apparent Tm=52°C. The unfolding of SAA in complex with POPC became 
thermodynamically irreversible, as evident from the hysteresis in the heating and 
cooling data (Fig. 4.3B, red), in agreement with previous reports (Jayaraman et al., 
2015).  
Interestingly, at low amounts of lipid corresponding to SAA:POPC ratios of 
1:0.5 to 1:2, the heating data represented a weighted average of two transitions. 
Both a reversible transition with Tm=17°C involving free SAA and an irreversible 
transition with Tm=52°C involving lipid-bound SAA were observed (Fig. 4.3A). At a 
1:5 SAA:POPC ratio the heating data showed only the lipid-bound SAA transition. 
Similarly, only the lipid-bound transition was observed at 1:10 to 1:80 SAA:POPC 
(Fig. 4.3B).   
Combining the structural and stability studies with the native gels, we were 
able to discern the details of lipid binding. First, the transition from lipid-free SAA 
to lipid-bound SAA accounted for the differences in both secondary structure and 
stability. At lower lipid amounts, 1:0.5 to 1:2 SAA:POPC, the lipid-free SAA band, 
together with the lipid-bound SAA, was observed on the native gel, and both 
transitions were observed in the CD melting data. Further, as the fraction of free 
protein decreased upon lipid addition, the helical content of SAA increased. At 1:5 
SAA:POPC, the native gel clearly showed that all protein was contained within 8-





Figure 4.3 Thermal stability of SAA-POPC complexes formed by 
spontaneous reconstitution. 
Heating and cooling data of SAA-POPC complexes were recorded by the far-UV 
CD signal at 222 nm to monitor α-helical unfolding and refolding. Protein:lipid ratios 
used to prepare these complexes are color-coded as indicated. Dotted lines 
represent the melting temperatures, Tm, of lipid-free (gray) and lipid-bound (red) 





a maximum and the melting data only showed the lipid-bound SAA transition. 
Together, these data show that at 1:5 SAA:POPC, SAA is completely in the lipid-
bound conformation and the 8-10 nm particles seen on the gel contain both protein 
and lipid. Lastly, in larger particles formed by absorption of SAA onto POPC SUV, 
there were no additional changes to the protein structure or stability. These 
observations indicate a similar lipid-bound structure and stability of SAA in HDL-
size particles and in SUV-bound forms.  
 
4.3 SAA-containing lipoproteins formed by cholate dialysis  
4.3.1 Formation of homogeneous SAA-POPC particles 
 Cholate dialysis is a well-established technique used to form model HDL 
particles in vitro. Sodium cholate, a bile salt, is used to solubilize a lipid dispersion, 
which is then introduced to the apolipoprotein of interest, most commonly apoA-I. 
The cholate is removed by dialysis, leading to the formation of relatively 
homogeneous protein-lipid particles (Jonas, 1986). We have used this method, 
substituting SAA for apoA-I as our protein of interest, to facilitate the formation of 
larger quantities of more homogeneous SAA-POPC particles with controlled 
composition.  
 Using this technique, we reconstituted SAA-POPC complexes at 
protein:lipid molar ratios of 1:10, 1:30, and 1:80. Each of the three mixtures showed 
a single broad band on the native PAGE. The average particle size increased with 




imaging using negative stain electron microscopy (Fig. 4.4, EM panels). Notably, 
at 1:10 SAA:POPC, the particles obtained by cholate dialysis and by spontaneous 
reconstitution both ran as a broad band corresponding to 8-10 nm size (Fig. 4.4 
and 4.1, 1:10 lanes). This result suggests that at 1:10 SAA:POPC ratio, HDL-size 
particles formed by different methods had similar stoichiometry. 
 
4.3.2 Structure of lipid-bound SAA-POPC lipoproteins of various sizes 
 Far-UV CD of the SAA-POPC particles formed using cholate dialysis 
revealed a lipid-induced α-helical folding in SAA, similar to that seen in the particles 
formed by spontaneous reconstitution. The far-UV spectra of SAA-POPC particles 
formed at 1:10, 1:30 or 1:80 protein:lipid ratios overlapped, illustrating that, once 
again, the lipid-bound structure of SAA was independent of the amount of lipid in 
the range explored (Fig. 4.5). The α-helical content in all lipid-bound SAA particles 
determined by CD based on the θ222 value was ~48%. 
To further explore the lipid-bound conformation of SAA, the environment of 
the three tryptophans in SAA (W18, W29 and W53) was monitored by fluorescence 
using an excitation wavelength of 280 nm, to excite both Trp and Tyr, or 295 nm, 
to selectively excite Trp. At 25°C the wavelength of maximal fluorescence, λmax, of 
lipid-free SAA, which was largely unfolded at this temperature, was max=352±1.5 
nm, indicating largely solvent-exposed Trp (Fig. 4.6A, black). At 5°C when free 





Figure 4.4 Size distribution of SAA-POPC complexes formed by cholate 
dialysis. 
Non-denaturing gel electrophoresis and negative stain electron micrographs of 
SAA-POPC complexes, which were reconstituted using cholate dialysis. 
SAA:POPC molar ratios of 1:10, 1:30 and 1:80 were used, resulting in a range of 







Figure 4.5 Secondary structure of SAA-POPC particles formed by cholate 
dialysis. 
Far-UV CD spectra of 1:10, 1:30 and 1:80 SA-POPC particles at 25C are color-
coded. The spectrum of lipid-free SAA is shown for comparison. Figure adapted 





observed (Fig. 4.6A, gray), indicating decreased Trp exposure to solvent. Lipid-
bound SAA in SAA-POPC lipoproteins showed an additional shift to max=337±1.5 
nm. Lipid-bound SAA displayed very similar intrinsic fluorescence spectra at 5°C 
and 25°C. Overall the 15 nm blue shift at 25 °C from lipid-free to lipid-bound SAA 
indicated substantial burial of Trp, which likely resulted from the combined effects 
of lipid binding and protein folding. A similar blue shift was observed at different 
SAA:POPC ratios in the range explored (Fig. 4.6A), which is consistent with a 
similar SAA conformation in different-size SAA-POPC particles.  
These Trp emission spectra supported our hypothesis that the apolar faces 
of the two amphipathic -helices, h1 (residues 1-27) and h3 (50-69), formed an 
extended lipid binding site in SAA (Chapter 3; Frame & Gursky, 2016). In fact, W18 
and W53 are located in the apolar lipid-binding faces of h1 and h3, while W29 is in 
the nearby loop (Fig.4.6B). Hence, lipid binding via these helical faces is expected 
to largely screen W18, W53 and perhaps W29 from the solvent, which is consistent 
with the observed value of max=337 nm indicating largely buried Trp in lipid-bound 
SAA at 25°C (Fig. 4.6A).  
 
4.3.3 Thermal remodeling of SAA-POPC lipoproteins 
 Next we explored the stability of the SAA-POPC particles formed by cholate 
dialysis using various protein:lipid ratios. The melting data of these particles largely 
overlapped and showed a thermodynamically irreversible helical unfolding (Fig. 






Figure 4.6 Intrinsic Trp fluorescence of SAA-POPC complexes. 
A) Normalized fluorescence emission spectra of 1:10, 1:30 and 1:80 SAA-POPC 
particles at 25°C monitored from 300 nm to 450 nm using an excitation 
wavelength of 295 nm. Emission spectra of lipid-free SAA at 5°C and 25°C are 
shown for comparison.  
B) X-ray crystal structure of mSAA3 (PDB ID 4Q5G) highlighting the location of 
the three Trp in mSAA1 (W18, W29, W53). mSAA3 has 80% sequence identity 
to mSAA1 and shares these three residues.  





1:80) very similar to Tm≈52±1.5°C observed in the spontaneously formed SAA-
POPC complexes (Fig. 4.3). Together, these results clearly showed that the 
secondary structural stability of lipid-bound SAA was very similar on the particles 
of different sizes prepared by different methods, and was much higher than that of 
lipid-free SAA.  
 To explore the irreversible nature of the transition observed in the melting 
experiments, lipoproteins formed by cholate dialysis were incubated at selected 
temperatures, 25°C, 45°C and 60°C, for 1 hr and then analyzed by native PAGE. 
These temperatures represented distinct stages in the unfolding of lipid-bound 
SAA: i) at 25°C it was fully folded, ii) at 45°C it began to unfold, and iii) at 60°C, it 
was unfolded. The native gel clearly showed a remodeling of the intact lipoproteins 
into larger and smaller particles (Fig. 4.7B), which correlated with the helical 
unfolding of SAA observed by CD.  
 The larger particles were apparent products of the heat-induced lipoprotein 
fusion. Interestingly, the smaller particles, which formed upon lipoprotein heating 
to 60°C followed by cooling to ambient temperature, were 8-10 nm (Fig. 4.7B) 
independent of the size of parent lipoproteins. This observation suggested that, 
while the parent lipoproteins formed by cholate dialysis were kinetically trapped 
and were irreversibly remodeled upon heating and cooling into larger and smaller 
particles, the small HDL-size particles resulting from such remodeling represented 






Figure 4.7 Thermal stability of SAA-POPC complexes formed by cholate 
dialysis. 
A) Heat-induced changes in the α-helical structure of SAA-POPC complexes 
monitored by far-UV CD signal at 222 nm. Melting and cooling data were 
collected from 5C - 65C at a rate of 60C/hr. Protein:lipid molar ratios are 
indicated and color-coded. Free SAA is shown as a comparison. 
B) Non-denaturing gel electrophoresis of 1:10, 1:30, and 1:80 SAA-POPC 
particles, which were incubated for 1 hr at 25C, 45C, or 60C. Asterisks 
indicate the same final state for each particle.   





4.3.4 Biochemical and biophysical analyses of the products of thermal remodeling  
 To further explore the nature of the larger and smaller particles post-melt, 
size-exclusion chromatography (SEC) was used to isolate them for 
characterization. For this, the 1:10 protein:lipid ratio was chosen because at this 
ratio the initial lipoproteins were 8-10 nm range in size, similar to the size of SAA-
POPC particles formed upon spontaneous reconstitution. These lipoproteins, 
which were formed by cholate dialysis, eluted as a single peak in SEC (Fig. 4.8A, 
blue) indicating that all protein was incorporated into lipoprotein particles, in 
agreement with the native gels (Fig. 4.4). Next we incubated 1:10 SAA:POPC 
particles at 60°C for 1 hr and then analyzed the elution profile on SEC. After sample 
heating, the elution profile showed a major peak (peak I) and two additional peaks; 
peak II, which was much broader, and peak III (Fig. 4.8A, purple). The peak 
fractions were collected and analyzed by native PAGE and negative stain EM. 
Peak II contained small vesicles with a size of >20 nm, peak I contained the 8-10 
nm particle, and peak III showed few smaller particles under 8 nm in size. (Fig. 
4.8B). 
 The far-UV spectra demonstrated that SAA was α-helical after heating; 
however, the helical content differed in each of the peak fractions. The spectrum 
for the major peak I overlapped with the intact sample, suggesting that the 
conformation in this particle population remained invariant upon heating. Peak II 
containing SAA bound to vesicles showed a 10% reduction in the helical content. 





Figure 4.8 Characterization of thermal remodeling of 1:10 SAA-POPC parent 
particles. Complexes were incubated for 1 hr at 60°C. 
A) SEC profiles of intact (blue) and heated (purple) SAA-POPC particles. Elution 
peaks for the heated sample are labeled I – III. Superose 6 10/300 GL column 
was calibrated with blue dextran as the void volume (8.1 ml), thyroglobulin 
(12.71 ml), aldolase (16.71 ml), ferritin (17.44 ml), ribonuclease A (18.99 ml) 
and aprotinin (21.7 ml). 
B) Non-denaturing gel electrophoresis of intact complexes and of the peak 
fractions isolated from the heated sample (labeled as in panel A).   
C) Electron micrographs of negatively stained peak fractions isolated by SEC from 
the heated sample. Bar size is 70 nm.  




as peaks I and II (Fig. 4.9A). Surprisingly, the CD melting data for each of the peak 
fractions showed a Tm~52°C, similar to that of the intact SAA particle (Fig. 4.9B). 
This suggested that SAA is bound to lipid in all three peaks. This was confirmed 
by intrinsic Trp fluorescence showing a λmax=337 nm for peak I (Fig. 4.9C).  
 Further, we determined the biochemical composition of the peaks I, II, and 
III. Protein concentration was determined using UV/Vis absorbance spectroscopy 
and lipid concentration was quantified using an enzymatic Phospholipid C assay 
(Wake Diagnostics). As expected, we found that the intact lipoprotein prior to 
heating contained a molar ratio of 1:10 SAA:POPC. Biochemical analysis of peak 
I revealed a protein-rich particle with a 1:6 SAA:POPC molar ratio. This result was 
consistent with the native PAGE showing slightly smaller particles (Fig. 4.8B) as 
compared with the intact lipoproteins. Furthermore, analysis of large particles in 
the peak II fraction showed a 1:25 SAA:POPC ratio, which was consistent with the 
protein-containing lipid vesicles observed by native PAGE and EM (Fig. 4.8B). In 
contrast, smaller particles in peak III showed 1:1 SAA:POPC molar ratio, which 






Figure 4.9 Secondary structure and thermal stability of SAA-POPC 
complexes isolated by SEC after thermal remodeling of 1:10 SAA-POPC 
particles.  
A) Far-UV CD spectra of isolated particles from peaks I, II, and III at 25°C. Intact 
SAA-POPC particles are shown as comparison. 
B) CD melting data at 222 nm recorded during heating and cooling at a constant 
rate. The melting temperature (Tm) for peak fraction I is indicated; intact SAA-
POPC complexes have a similar Tm. Intact SAA-POPC particles are shown 
(black dashed) as comparison. 
C) Trp emission spectra for each isolated particle from peaks I, II, and III using an 
excitation wavelength of 295 nm.  





4.4 SAA can sequester phospholipids and their hydrolytic products 
 A caveat of the methods we used to reconstitute SAA-only lipoproteins is 
that they promote lipid hydrolysis. The sonication used to form POPC SUV for 
spontaneous reconstitution, as well as the heating used for remodeling of the SAA-
POPC particles result in partial POPC hydrolysis to form oleic acid and lysoPC 
(Hauser, 1971; Batzri & Korn, 1973, Grit et al. 1989). Our lab, and others, have 
demonstrated that SAA can bind to these products of phospholipid hydrolysis and 
form ~8 nm particles (Tanaka et al. 2017, Jayaraman et al. 2018). Therefore, it 
was important for us to show that SAA can bind intact phospholipids by using a 
system that minimizes the phospholipid hydrolysis. To do so, we incubated SAA 
with POPC multilamellar vesicles (MLV) at two ratios, 1:10 and 1:80. At both of 
these ratios, 8-10 nm SAA particles were seen on the native PAGE (Fig. 4.10), 
indicating that SAA solubilized POPC MLV and spontaneously formed HDL-size 
particles. Later studies in our lab by Dr. Jayaraman suggest that this ability of SAA 
to solubilize phospholipids and their hydrolytic products represents a vital role of 
SAA to promote clearance of cell membrane debris from sites of injury (Jayaraman 





Figure 4.10 SAA remodels phospholipid vesicles in a spontaneous energy-
independent process. 
Non-denaturing gel electrophoresis of SAA-POPC complexes formed by 
spontaneous reconstitution with either multilamellar vesicles (MLV) or small 






4.5 Cholesterol does not alter the structure or stability of SAA-POPC 
particles  
Cholesterol is an essential component of cell membranes and lipoproteins. 
To determine how the addition of cholesterol affects SAA-containing lipoproteins, 
we reconstituted ternary complexes of SAA:POPC:cholesterol using molar ratios 
of 1:30:2 and 1:80:4, which had been previously established to mimic those in HDL 
(Cavigiolio et al. 2008). These ternary complexes were compared with the binary 
complexes of SAA:POPC at 1:30 and 1:80 molar ratios, respectively. Native PAGE 
demonstrated that the addition of cholesterol led to an increase in the particle size 
(Fig. 4.11A); a similar trend has been observed for lipid complexes with other 
apolipoproteins (Jayaraman et al. 2010). The incorporation of cholesterol did not 
have a large effect on the structure or stability of the SAA-containing particles. Far-
UV CD spectra showed a marginally significant decrease in amplitude 
corresponding to a ~6% decrease in the -helical content upon cholesterol 
incorporation (Fig. 4.11B). Intrinsic Trp fluorescence showed no significant 
spectral changes upon cholesterol incorporation (Fig. 4.11C). Lastly, far-UV CD 
melting data did not show any major changes upon cholesterol incorporation (Fig. 
4.11D). These trends were consistent with the effects of cholesterol on the 
structure and stability of other apolipoprotein-PC complexes (Jayaraman et al., 
2010). Furthermore, cholesterol did not affect the hysteresis in the melting data, 






Figure 4.11 Effects of cholesterol on SAA-POPC particle structure and stability. 
A) Non-denaturing gel electrophoresis of intact particles. Complexes with 
SAA:POPC:Cholesterol molar ratios 1:30:2 or 1:80:4 were reconstituted by 
cholate dialysis. Cholesterol-free particles of 1:30 and 1:80 SAA:POPC are 
shown for comparison. 
B) Far-UV CD spectra of SAA-POPC particles at 25C. 
C) Trp emission spectra of SAA-POPC particles (red and purple) at 25C show a 




D) CD heating and cooling data of the SAA-POPC complexes. Line coding is as 
in panels A and B. Arrows show directions of temperature changes. 
E) Native PAGE of SAA:POPC and SAA:POPC:cholesterol complexes that were 





free particles. This was confirmed by the presence of 8-10 nm particles on the 
native gel after thermal remodeling of SAA:POPC:Ch particles (Fig. 4.11E).  
 
4.6 Effect of anionic lipids on the structure and stability of SAA-containing 
lipoproteins 
Circulating SAA is associated with the subfraction of dense HDL termed 
HDL3, (Coetzee et al., 1986) that contains small amounts of anionic lipids such as 
phosphatidylserine (PS) (Skipski et al. 1966, Kontush et al. 2013). PS is 
preferentially located in the inner leaflet of the plasma membrane, and increased 
PS exposure upon damage to the cell membrane activates innate immunity, 
including SAA overproduction (Seong & Matzinger, 2004; Matzinger 2007). 
Another anionic lipid that is a ubiquitous minor component of cell membranes is 
phosphatidylglycerol (PG) (Kontush et al. 2013).  
To probe the effects of these phospholipids on the structure and remodeling 
of SAA-containing lipoproteins, we used cholate dialysis to reconstitute complexes 
containing SAA:POPC:PS:POPG at a molar ratio of 1:64:8:8. Far-UV CD spectra 
showed a small decrease in amplitude corresponding to ~8% decrease in α-helical 
content (Fig. 4.12A). However, no significant changes in the λmax were observed 
by intrinsic Trp fluorescence (Figure 4.12B). Native gels of SAA complexes 
containing anionic phospholipids showed a similar remodeling as that seen in SAA-






Figure 4.12 Effects of anionic phospholipids on SAA-POPC particle structure 
and stability.  
A) Far-UV CD spectrum of SAA particles formed with POPC, PS and POPG at a 
molar ratio of 1:64:8:8. The far-UV CD spectrum of 1:80 SAA:POPC particles 
is shown as a comparison. 
B) Fluorescence emission spectra using an excitation wavelength of 280 nm. Free 
SAA at 5°C (gray) and 25°C (black) are shown to highlight the blue shift in Trp 
emission as a result of lipid binding.  
C) Non-denaturing gel electrophoresis of SAA:POPC:PS:POPG particle after 1 hr 





resulted in the formation of larger particles that did not enter the gel, as well as 
smaller HDL-size particles in the 8-11 nm size range (Fig. 4.12C).  
Overall, the structural properties of lipid-bound SAA remained consistent 
upon the incorporation of cholesterol or anionic lipids into SAA-POPC complexes. 
The ability to bind to various lipids of the plasma membrane in addition to PC 
further supports our idea that SAA can act as a lipid scavenger.  
 
4.7 Structure of SAA-only lipoproteins and a potential function in the acute-
phase response 
The studies described in this chapter show that SAA formed HDL-size 
complexes with lipids over a wide range of conditions. These particles were formed 
through spontaneous reconstitution or upon heating of intact lipoproteins using 
various lipids at different amounts. The fact that these 8-10 nm particles formed 
using a wide range of temperatures and protein:lipid ratios suggests that these 
complexes represented a stable, kinetically accessible structure and similar 
structures could form in vivo.   
Despite their HDL-like size, the stoichiometry of the stable SAA-POPC 
complexes was distinct from HDL. The 1:6 SAA:POPC molar ratio determined from 
the biochemical analysis of these particles after heating corresponds to a 2.5:1 
mg:mg protein:lipid ratio. In comparison, normal plasma HDL contain comparable 
amounts of protein and lipid by weight. Consequently, the HDL-size particles in 




compared to HDL. Based on the migration on the native gel, the average molecular 
weight for the HDL-size particles is close to 200 kDa. Combining this with the 
SAA:POPC ratio determined by the protein and phospholipid analysis, we suggest 
that each particle contains on average about 12 SAA and 72 POPC molecules.  
We posit that several SAA molecules together spontaneously solubilize 
membranes by binding and encapsulating lipids via their curved hydrophobic 
surface to form nanoparticles such as those observed in the current study. 
These structures could represent an important function of SAA that 
precedes HDL binding. The ability to remodel and package lipids suggests that 
SAA can facilitate rapid clearance of cell debris from the sites of injury. Moreover, 
recent studies from our laboratory show that such SAA-phospholipid particles 
provide substrates and remove products of secretory phospholipase A2, 
suggesting synergistic roles of these two acute-phase proteins in lipid clearance 
(Jayaraman et al. 2019). Finally, the relatively high stability of the SAA-lipid 
complexes helps protect from the rapid degradation and misfolding of SAA that 





CHAPTER FIVE: Local Protein Conformation and Identification of the 
Phospholipid Binding Site 
5.1 Introduction  
Despite advancements in structural studies of SAA, the connection between 
the protein structure free in solution, on model lipoproteins, and in the crystals is 
unclear. We and others have shown that SAA is largely unordered in solution, only 
~25% α-helical at 5°C, and obtains ~50% α-helical structure upon binding to 
phospholipids (Takase et al. 2014, Jayaraman et al. 2015, Frame et al. 2017); 
however, lipid-bound SAA is still much less structured than ~75-80% α-helix 
observed in the crystals (Lu et al. 2014, Derebe et al. 2014). Here we aimed to 
determine the lipid-binding site in SAA and establish the link between the crystal 
structure of this protein and its conformation in solution and on model lipoproteins.  
Our bioinformatics and structural analyses compelled us to propose that the 
lipid-binding site in SAA is comprised of the two amphipathic α-helices, h1 and h3 
(Chapter 3). The three available crystal structures supported this idea and showed 
that h1 and h3 are on the same side of the SAA monomer and form a solvent-
exposed hydrophobic surface. The curvature of this surface conforms to the size 
of HDL, suggesting that the SAA monomer binds to HDL through this surface 
(Frame et al., 2016).  
Our proposed lipid-binding site encompassed previously identified regions 




2009). Since previous studies relied on the use of monoclonal antibodies or SAA 
protein fragments, what was still missing was the direct identification of the lipid-
binding site in intact full-length SAA.  
Our data presented in Chapter 4 provided indirect evidence that intact SAA 
binds to lipids through the hydrophobic face formed by h1 and h3. The blue shift 
seen in the intrinsic Trp fluorescence spectra indicated a shift of the Trp residues 
to a buried, apolar environment. The three Trp residues in SAA are located in or 
adjacent to this apolar surface, suggesting that this face is the site of lipid binding.  
The current chapter reports a detailed hydrogen-deuterium exchange 
(HDX) mass spectrometry (MS) analysis of the conformation of full-length SAA 
lipid-free in solution and in SAA-POPC complexes. This is the first use of HDX to 
probe the structure of SAA. Our results directly identify the lipid-binding site in full-
length SAA and provide a mechanism explaining how lipid binding induces ordered 
structure in this intrinsically disordered protein. The results also establish the link 
between the protein conformation free in solution, in model lipoproteins, and in the 
crystallized state, and provide novel insights into the protein conformational 
changes involved in lipid binding.  
 
5.2 The use of HDX-MS in SAA studies 
To identify the local conformation in free SAA in solution and its changes 







Figure 5.1 Peptide coverage map for HDX MS experiments 
A) Peptide coverage map for experiments run at 5°C. 33 total peptides were monitored covering 95.1% of the SAA 
sequence. Peptide overlap provided a redundancy of 5 peptides/amino acid. 
B) Peptide coverage map for experiments run at 15°C and 25°C. 33 total peptides were monitored covering 100% 




deuterium uptake depends on multiple factors, including solvent exposure and 
main-chain hydrogen bonding (see Chapter 2 for detail). Therefore, by monitoring 
the amount of uptake in each peptic fragment over time, we can get a sense of 
whether specific protein regions are involved in lipid binding and are in an α-helical 
conformation. The details obtained by HDX MS are limited by the peptide length, 
but can approach near-residue resolution if the peptide length and redundancy (i.e. 
overlap among different peptides) are optimized. Ideally, the peptide coverage 
should approach 100%, and high redundancy is desirable. In our study, the 
optimized enzymatic digestion of SAA in lipid-free and POPC-bound states at 0C 
resulted in 95.1% protein coverage represented by 33 peptides, with a redundancy 
of 5.00 peptides/amino acid (Fig. 5.1A).  
The mass-to-charge ratio of each peptide was monitored for lipid-free and 
lipid-bound SAA, at various deuterium labeling time points of 0s, 5s, 10s, 
3min,10min, 30min, 1h, and 4h. At each time point, the experimental m/z for each 
peptide was matched with the calculated m/z value for each peptide based on the 
theoretical uptake by this peptide, using the Dynamix program (Fig. 5.2). The 
deuterium uptake was calculated based on the centroid of the spectral plots, and 
uptake plots were constructed comparing the deuterium uptake at each time point 




















Figure 5.2 Spectral plots for lipid-free and lipid-bound SAA at 5°C 
Representative series of spectral plots for all peptides in lipid-free (left) and lipid-
bound (right) SAA, at 5°C. Movement of the centroid from the unlabeled state 
towards higher m/z represented deuterium incorporation at the amide nitrogen. 
Spectra were used to calculate deuterium incorporation and create uptake plots 







Figure 5.3 Deuterium uptake plots for each peptide for lipid-free vs. lipid-
bound SAA at 5°C. 
Complete set of uptake plots depicting the amount of deuterium uptake at each 





Most experiments were run at 5C where the H-D exchange rate is relatively 
slow. At this temperature, the labeling and digestion were optimal for lipid-free SAA 
that shows a relatively fast exchange and fast proteolytic digestion characteristic 
of an intrinsically disordered protein. Additionally, one set of data was recorded for 
each sample at 15C and at 25C to approach more physiologic temperatures and 
to amplify the difference in the deuterium uptake by the lipid-free and lipid-bound 
protein. For these additional data sets, identical enzymatic digestion conditions 
gave 100% protein coverage represented by 33 peptides with a 4.93 
peptide/amino acid redundancy (Fig. 5.1B); labeling times monitored at 15°C and 
25°C were 10s, 1m, 10m, 1h, and 4h. The results of these experiments are 
described below. 
 
5.3 HDX reveals that key features of the SAA solution conformation are 
retained in the crystal structure   
 
5.3.1 Insights into solution conformation of free SAA at 5°C 
 The deuterium uptake for each polypeptide at each labeling time point is 
displayed as a percentage of the maximal theoretical uptake (Fig. 5.4A). Overall, 
the uptake by each peptide of lipid-free SAA progressively increased over time, 
reaching 40-60% of the maximal theoretical uptake at 4 hours. However, in the 
polypeptides located in residues corresponding to h1, h2 and h3 from the crystal 




protection in this region. This increased protection indicated that helical structure 
in free SAA in solution observed at 5°C must be located mainly in the N-terminal 
half of the protein.  
Importantly, x-ray crystallography and HDX of free SAA showed very similar 
trends in the local dynamics. This was apparent when the main chain B-factors 
obtained by x-ray crystallography (Fig. 5.4A, schematic) were compared with the 
rate of exchange determined by HDX (Fig. 5.4A).  In fact, helices h1 and the h2-
h3 stretch had lower B-factors as compared to the residue segment 65-103 
encompassing h4, h’ and the C-terminal tail. This parallels the relative protection 
of these regions observed in free SAA by HDX. Moreover, the interhelical linkers 
observed by crystallography also showed distinct structural protection by HDX-MS. 
The h1-h2 linker, which was contained within the peptide 24-34 in our study, 
was less protected than the adjacent segments from both h1 and h2, in agreement 
with the B-factors observed by crystallography.  Importantly, the h2-h3 linker 
(encompassed by peptides 43-52, 44-52, 53-59 and 53-60 in our HDX 
experiments) showed comparable or greater protection than that in the adjacent 
segments from h2 and h3. Unexpectedly, this linker, which contains the GPGG 
motif that is 100% conserved through evolution, showed low B-factors in the crystal 
structures.  Our previous analysis identified the tight inter-helical turn formed by 
this GPGG motif located at the central vertex of the SAA molecule (Frame & 
Gursky, 2016). Hence, despite its high potential flexibility, the GPGG motif formed 





Figure 5.4 Data summary showing deuterium uptake for lipid-free SAA. 
A) Percent deuterium uptake by each peptide at 5°C. Schematic on the right is linear 
representation of the secondary structure (rectangles – helices, line – turns and 
loops) colored in accordance with the B-factors from the x-ray crystal structure. 
B) Deuterium uptake by lipid-free SAA at 15°C and 25°C. Secondary structure 




Interestingly, the structural protection observed by HDX in the linker 
between h3 and h4 differed from that seen in the crystal structures. This linker is 
represented by peptides 68-77 and 69-75, which also contain the beginning of h4. 
In the crystal structures, the h3-h4 linker consistently had higher B-factors that its 
neighboring segments; however, in HDX, the deuterium uptake in these peptides 
was less than that in the neighboring segments. In the SAA protein family, the h3-
h4 linker has variable length and composition; moreover, the beginning of h4 
contains the cleavage site that releases the major residue fragments 1-76 found in 
amyloid deposits in vivo (Westermark, Fandrich, & Westermark, 2015). Therefore, 
high structural protection observed in this region by HDX of free SAA was 
unexpected. This observation suggests that the conformation of the h3-h4 linker is 
different in the crystal structure and in solution. Ongoing molecular dynamics 
simulations by our collaborators suggested that the h3-h4 linker forms a short helix 
in solution (work in progress). 
Lastly, a short linker at residues 89-90 (contained within the peptide 78-93 
in our HDX study) showed slightly greater protection as compared to its adjacent 
helical segments, which mirrors the relatively well-ordered structure observed by 
crystallography at the end of h4 and extending into the C-terminal tail. Substantial 
structural protection in this region observed by HDX suggests that, although the α-
helical structure of lipid-free SAA in solution is likely located in the N-terminal, the 





5.3.2 Temperature-dependent changes in deuterium labeling and solution 
conformation of SAA at 5-25°C  
The labeling with deuterium was repeated at 15C and 25C, and the results 
were compared with those at 5°C. These temperatures were chosen as they 
represented distinct positions along the thermal unfolding curve of lipid-free SAA: 
5°C is in the pre-transitional range where the protein is 25% helical, 15°C is close 
to the unfolding midpoint Tm=18C, while at 25C SAA was completely unfolded 
(Chapter 4, Frame et al. 2017). Due to the combination of both α-helical unfolding 
and increased rate of labeling at higher temperatures, the deuterium uptake was 
expected and observed to be progressively amplified from 5°C to 15°C to 25°C 
(Fig. 5.4B).  
One region of particular interest was h2-h3. The peptides in this region 
showed progressive increase in labeling as the temperature increased from 5°C to 
25°C. This increase was much larger than in the rest of the protein, suggesting 
that, in addition to the increased overall labeling rate, there was also unfolding in 
this region. This supports our idea that at 5°C the majority of the helical structure 
was in the N-terminal half of the protein, and this structure unfolded at 25°C. The 
only region of lipid-free SAA that seemed to retain protection at 25°C were portions 
of h1 and around the h3-h4 linker. Previously, h1 was implicated in self-association 
of free SAA in solution (Wang & Colon, 2004), which could contribute to the 
retained protection in this region. Additionally, molecular dynamics simulations of 




these experiments is that at 15°C and 25°C, the data quality decreased and not all 
peptides could be monitored by HDX MS.  
 
5.4 SAA-POPC lipoproteins of various sizes have similar protection 
Next, we used HDX MS to analyze protein conformation in SAA-POPC 
complexes. To determine if the protein conformation was affected by the size of 
the lipoprotein particle, we compared HDX MS data recorded from the SAA-POPC 
particles reconstituted using cholate dialysis at 1:10, 1:30 and 1:80 protein-lipid 
ratios. The sizes of these particles ranged from 10 nm (1:10) to ~22 nm (1:80) 
(Chapter 4; Frame et al. 2017). The results showed a virtual overlap in the uptake 
plots for the particles of different sizes (Fig. 5.5). These results ascertained our 
previous findings using CD and fluorescence spectroscopy, which indicated very 
similar overall protein conformation on model lipoproteins of various sizes (Chapter 
4; Frame et al. 2017). Therefore, we focused our detailed HDX analysis on the 
1:10 SAA-POPC particles which, as we previously showed form the most 
thermodynamically stable species (Chapter 4; Frame et al. 2017) and resemble 






Figure 5.5 Deuterium uptake plots for SAA-POPC particles of different sizes 
at 5°C.  
The protein:lipid molar ratios are marked and color-coded. The particle sizes at 
these ratios ranged from ~10 nm (at 1:10 SAA:POPC) to ~22 nm (at 1:80 
SAA:POPC). The results show no significant size-dependent differences in the 





5.5 Lipid binding increases structural protection of SAA 
 The data for lipid-bound SAA showed a general trend of decreased and 
slower uptake than that seen for lipid-free SAA (Fig. 5.2). At 5°C the greatest 
protection in lipid-free SAA was observed in the regions located in h1 and h3, while 
h2 and h4 showed a lesser degree of protection (Fig. 5.6A). Looking more closely 
at the linkers, similar trends carried over to SAA-POPC. Specifically, the linker 
between h1-h2, which is encompassed by the peptide 24-34, showed increased 
uptake, compared to the neighboring peptides; the linker between h2-h3, 
containing the GPGG sequence, was as well protected as the neighboring 
peptides. Interestingly, the linker between h3-h4 displayed the same unexpected 
phenomenon where it was better protected than the residues in h4; however, it 
was less well ordered than the residues in h3.  
In addition to 5°C, the labeling of SAA-POPC was carried out at 15°C and 
25°C. Overall, the increase in temperature resulted in increased uptake. At all 
temperatures h1 and h3 displayed less uptake than the rest of the protein (Fig. 
5.6B). Moreover, the trends in the helical linkers were also similar at all 
temperatures. This was not surprising, as the helical content of lipid-bound SAA, 
which has a Tm~52°C, did not vary at these temperatures (Chapter 4, Frame et al., 
2017). Therefore, the increased uptake observed in SAA-POPC at 15°C and 25°C 
was due entirely to the faster exchange rate at higher temperatures. Taken 






Figure 5.6 Deuterium uptake for SAA-POPC. The lipoproteins were prepared 
using 1:10 protein:lipid molar ratio.  
A) Percent deuterium uptake by each peptide at 5°C. Schematic on the right is linear 
representation of the secondary structure determined by x-ray crystallography. 
B) Percent deuterium uptake at 15°C and 25°C. Secondary structure schematic 




especially the helical and linker regions in the N-terminal half of SAA, directly relate 
to the conformation of lipid-bound SAA. 
 
5.6 Helical segments h1 and h3 compose the lipid-binding site of SAA 
 To determine the exact regions of lipid-induced structural changes, the 
deuterium uptake by lipid-bound and lipid-free SAA at 5°C was compared (Fig. 
5.7). Lipid binding induced increased protection throughout the entire protein. The 
largest increase was observed in peptides encompassing h3, particularly in 
residues 54-65 and 61-68 (Fig. 5.7, Fig. 5.8). This strongly implicates h3 as part of 
the lipid-binding site wherein folding in the C-terminal half of the helix is induced 
by the lipid binding. In contrast with the C-terminal half of h3, the h2-h3 linker, 
which was already well ordered in the lipid-free protein, showed only a slight 
increase in protection in the lipid-bound state.  Peptides containing the h3-h4 
linker, specifically 66-77, 66-78, 69-78, 69-80, and 70-76, showed little or no 
increased protection upon lipid binding. The fact that the largest increase is 
towards the h2-h3 linker and does not propagate to the h3-h4 linker or into h4, 
suggested that the lipid-induced increase in helical content is contained in h3.  
 The lipid-induced increase in the structural protection of  h3 at 5°C (Fig. 5.7 
A), which was amplified at 15°C and 25°C (Fig. 5.7B), provided direct experimental 
confirmation of our hypothesis that the amphipathic α-helix, h3, formed part of the 
lipid-binding site in SAA. To our knowledge, this is the first study directly implicating 




 Two interesting observations from the difference plots between lipid-bound 
and lipid-free were noticed. First, there was little increased protection observed in 
h1 at 5°C upon lipid-binding (Fig. 5.7A), contrary to what we expected based on 
both our bioinformatics analyses (Chapter 3; Frame & Gursky, 2016) and past 
literature that specifically identified the N-terminus as responsible for lipid-binding 
(Liang et al. 1996, Ohta et al. 2009). We posit that our observation was a result of 
SAA-lipid binding competing with SAA self-association in this region (Wang & 
Colon, 2004). At 15°C and 25°C, when free SAA loses structure, we did see 
increased protection in h1 signifying lipid binding, but the protection was not to the 
same degree as that seen in h3 (Fig. 5.7B). Second, we noticed that at all 
temperatures, lipid binding led to a decrease in protection in the h1-h2 linker (Fig. 
5.7). Ongoing molecular dynamics simulations have helped explain this 
observation, by suggesting a β-hairpin formation in lipid-free SAA. This β-hairpin 






Figure 5.7 Difference in deuterium uptake between lipid-bound and lipid-free 
SAA. 
A) Difference in percent deuterium uptake, SAA-POPC – SAA, between lipid-bound 
and lipid-free SAA for each peptide at 5°C. 
B) Similar differences at 15°C and 25°C. Secondary structure schematic displays 





Figure 5.8 Uptake plots of lipid-free and lipid-bound SAA 
Time-course of deuterium uptake for selected regions of SAA and SAA-POPC 
measured by HDX-MS. Data for SAA and SAA-POPC are color-coded as indicated 





5.7 Lipid binding increases protection in the C-terminal half of SAA 
 Surprisingly, in addition to the increased protection seen in h1 and h3, a 
lipid-induced increase in protection was also observed in the C-terminal end of 
SAA, especially in h4 (Fig. 5.7). This protection was most pronounced at the early 
time points, and dissipated over time, and the results were consistent at all 
temperatures explored. Previous studies by several teams including ours showed 
that lipid binding protects SAA from proteolysis and misfolding in vitro (Jayaraman 
et al. 2018). This was thought to be a result of the lipid protecting the major 
cleavage site, located between residues 76 and 77 in the h3-h4 linker 
(Westermark, Fandrich, & Westermark, 2015). Limited proteolysis studies showed 
that the proteolysis of SAA by trypsin is delayed but not inhibited upon lipid binding 
(Fig. 5.9; Jayaraman et al., 2018). Further, MS analysis showed that similar tryptic 
fragments were generated in the lipid-bound and lipid-free SAA (Jayaraman et al., 
2018). Taken together with HDX-MS, these results suggest that the lipid-induced 
protection of this and other cleavage sites results from protein-protein contacts 
between the largely non-helical C-terminal half of the SAA molecule and the 
helices in the N-terminal half, rather than from direct lipid binding to the C-terminal 







Figure 5.9 Lipid binding delays SAA proteolysis. 
 Limited proteolysis of lipid-free SAA and SAA-POPC was performed by trypsin 
and the results were analyzed by SDS PAGE. Lipid-free and lipid-bound SAA 
were incubated with trypsin at 1:200 wt:wt ratio SAA:trypsin for the indicated 





5.8 Binding to phospholipids selectively stabilizes the well-ordered protein 
conformation 
Next, we explored the presence of alternative conformations in lipid-free 
and lipid-bound SAA. Spectral envelopes for each peptic fragment were analyzed 
for the presence of EX1 and EX2 kinetics (Weis et al. 2006). EX2 kinetics is 
predominant in globular proteins and is represented by a single spectral envelope 
that shifts to higher m/z over time. On the other hand, EX1 is represented by a 
bimodal distribution of two spectral envelopes that differ in m/z or spectral 
broadening when the two m/z are similar. EX1 kinetics is typically present in 
regions where there is local disorder and/or the coexistence of alternative 
conformations.  At 5°C in lipid-free protein the majority of peptides displayed typical 
EX2 kinetics, but a subset of peptides consistently displayed EX1 (Fig. 5.10).  
These peptides included residues 7-18, 45-53, and 54-65. Each of these peptides 
displayed one state that underwent fast exchange, representing the open 
conformation, and another state with slow exchange that represented the folded 
state. For example, peptide 45-53, which contains the GPGG motif, showed a peak 
to the right of the undeuterated peak at 5 seconds (Fig. 5.10). This represents an 
open and flexible conformation that undergoes rapid exchange; in contrast, the left 
peak, which overlaps the undeuterated peak, represents slow exchange, as seen 
by the slow change in labeling over time. This slower exchange represents the 
folded state, with the GPGG motif in a closed conformation. When the three 




mapped onto the crystal structures, we noticed that that they are packed against 
each other at the central vertex formed by the tight turn at h2-h3 (Fig. 5.10). 
 In contrast to free protein, lipid-bound SAA displayed a shift towards EX2 
with only a slow-exchanging component observed in these peptides, indicating a 
shift towards a single highly protected conformer (Fig. 5.10) that resembles the 
closed conformation seen in the free protein. Our interpretation of these data is 
that in the region around the GPGG motif, lipid binding stabilizes SAA in the folded 
conformation that pre-exists in solution but is marginally stable and undergoes 
local folding and unfolding in the absence of the bound lipid.  
At 15°C, which is close to the thermal unfolding midpoint of free SAA, 
Tm~18°C, lipid-free SAA more clearly showed EX1 in these peptides (Fig. 5.11), 
with the protein fluctuating between the highly protected and unprotected 
conformation that showed comparable populations. Once again, a lipid-induced 
shift from EX1 to EX2 was observed reflecting a shift to a single dominant highly 
protected conformation.  
Taken together, our results suggested that lipid binding selectively 
stabilized the well-ordered conformation in the central vertex. In this region of SAA, 
lipid binding follows the conformational selection model, stabilizing an existing 
conformation that was present in the lipid-free SAA. We propose that this well-
ordered conformation resembles that seen in the crystal structures, with the GPGG 
motif forming a tight well-ordered interhelical linker between h2 and h3, while in 





Figure 5.10 Deuterium uptake kinetics of SAA and SAA-POPC at 5°C 
Spectral envelopes for selected peptides of SAA are shown. In free SAA, two 
peaks characteristic of EX1 are observed in residue segments 7-18 (blue), 45-53 
(green), and 54-65 (yellow), located in h1 and h3. These segments are mapped 
on the crystal structure below. All other segments in free SAA, and all segments in 
lipid-bound SAA, show only one peak corresponding to EX2. Data for a segment 
from the C-terminal part of SAA, which shows EX2 in both lipid-free and lipid-bound 








Figure 5.11 Deuterium uptake kinetics of lipid-free and lipid-bound SAA at 15°C. 
Spectral envelopes for selected peptides that represent the entire protein are shown. Two peaks showing EX1 





5.9 Summary  
 Our HDX-MS studies provide detailed insights into the solution 
conformation of lipid-free SAA and its lipid-induced α-helical folding. The HDX MS 
data of lipid-free and lipid-bound mSAA1 agree, in remarkable detail, with the 
existing crystal structures of hSAA1 and mSAA3. This agreement is exemplified 
by the direct correlation between the structural protection observed by HDX MS 
and the crystallographic B-factors in specific protein regions. This agreement was 
unexpected given the large differences in the α-helical content observed by CD: 
lipid-free SAA is disordered at room temperatures and obtains ~25% α-helix at 
5°C, lipid-bound SAA is ~50% α-helical, and SAA in the crystal structures was ~75-
80% α-helical. This agreement confirms that the crystal structure depicts key 
aspects of the solution conformation of SAA and therefore, is a useful model for 
understanding the solution conformation of this intrinsically disordered protein in 
both the lipid-free and lipid-bound states. 
The HDX MS results show that the helical structure of free SAA in solution 
is likely located in the N-terminal half of the protein. Lipid binding leads to a large 
increase in protection, particularly in h3, apparently inducing α-helical folding in 
this region.  These experiments substantiate our structural model wherein the 
concave apolar face formed by h1 and h3 forms the lipid binding site in SAA. In 
addition, our results reveal conformational changes in specific regions of SAA that 




with elements of induced fit, wherein ligand binding induces protein folding, and 
conformation selection, wherein ligand binding preferentially stabilizes a pre-
existing conformation. In particular, lipid binding by h3 induces helical folding, 
following induced fit. However, lipid binding also leads to a shift towards a pre-
existing, well-ordered conformation in the GPGG motif in the h2-h3 linker and the 
h1 segment that packs against it, following the conformational selection model. 
Specifically, we have described the GPGG domain in the h2-h3 linker, as well as 
residues in h1, as being either flexible or structured and shown that the lipid 
stabilizes the structured conformation at all temperatures. 
In summary, by integrating our HDX MD analysis with the results of x-ray 
crystallography, CD spectroscopy and other methods, we have described, for the 
first time, the solution conformation of SAA, have directly identified the lipid-binding 
site, and have provided mechanistic details of how lipid binding at this site induces 
ordered structure in this intrinsically disordered protein. These results establish the 
structural basis necessary for understanding the beneficial function of SAA in lipid 







CHAPTER SIX: Summary and Future Directions 
6.1 Summary of this dissertation research 
 Our structural and biophysical studies have elucidated many novel details 
describing the solution conformation of SAA and its interactions with its major 
functional lipids, phospholipids. Previously, it was unclear how the crystal structure 
related to the partially folded lipid-bound SAA structure or to the IDP structure of 
ligand-free SAA in solution. Additionally, the lipid-binding site in SAA was unclear 
and the mechanism underlying the lipid-induced helical folding was unknown. Our 
integration of diverse techniques including bioinformatics, CD spectroscopy, and 
HDX MS answered many of these questions. 
 First, we demonstrated that the crystal structure is directly relevant to the 
solution conformation of the lipid-free SAA. Our HDX MS data indicated that most 
α-helical structure in lipid-free SAA in solution was located in specific regions of h1 
and h2-3 from the N-terminal half of the molecule. Further, the relative uptake not 
only in the helical but also in the linker regions, such as the h1-h2 and h2-h3 
linkers, as well as in the C-terminal tail, correlated with the crystallographic B-
factors, suggesting that the local protein conformation in these regions resembled 
that seen in the crystal structure. The only discrepancy we identified between the 
crystal and the solution conformation was in the h3-h4 linker, which was better 
ordered in solution than expected.  Preliminary results of the ongoing molecular 
dynamics simulations, carried out by our collaborators in the laboratory of Dr. John 




 Second, we described the SAA-lipid interactions. Our bioinformatics studies 
suggested that h1 and h3 form a curved hydrophobic face that can bind to lipids, 
including HDL. This idea was verified experimentally in HDX MS studies which 
clearly identified h3 as integral to the lipid-binding site. Ongoing molecular 
dynamics simulations by our collaborators further support this idea and indicate 
that h1 and h3 form the lipid binding site in SAA.  
Our biochemical and biophysical studies showed that SAA can be 
reconstituted into lipoproteins that varied in size from about 10 to 22 nm based on 
the protein to lipid ratio; however, thermodynamically stable SAA-POPC particles 
were approximately 10 nm in size, typical of HDL. In all these POPC-containing 
particles, SAA showed similar ~45-50% α-helical content by CD and similar 
thermal stability, with Tm~52°C, much higher than that in free protein (Tm~18°C). 
We expanded upon these findings to show that on all these particles, the SAA 
structural protection determined by HDX MS, as well as intrinsic Trp fluorescence, 
which reports on protein-lipid interactions, were independent of the lipoprotein size. 
Despite these advances, there are still unresolved questions regarding the 
SAA structure in solution and in lipoproteins, which we would like to address. First, 
we aim to better define the solution conformation of SAA. We still do not have 
residue-specific details because of the limited resolution of the HDX MS. Next, we 
would like to better ascertain the lipid-binding site in SAA. Our HDX MS data clearly 
showed that h3 folds upon lipid binding, suggesting its direct involvement in lipid 




lipid, probably because this helix is involved in SAA self-association in solution.  
Even though h1 has been previously identified as a binding site for HDL and 
cholesterol, which is also supported by our EX1/EX2 analysis showing the h1 shifts 
to a more protected conformation upon lipid-binding, we would like to directly show 
by the same method that the hydrophobic face formed by h1 and h3 binds lipids. 
Lastly, we want to determine the structure of the SAA-containing lipoproteins that 
spontaneously formed in our studies. We have identified the protein:lipid ratio in 
these lipoproteins; however, we do not know how the protein and lipids pack 
together. To address these questions, our collaborators Meera Kumanan and 
Asanga Bandara in the laboratory of Dr. John E. Straub in the Department of 
Chemistry at Boston University are running a series of molecular dynamics 
simulations. These simulations are briefly outlined below. 
 
6.2 Molecular dynamics will provide detailed insights into the solution 
conformation of lipid-free and lipid-bound SAA 
6.2.1 Solution structure of SAA: comparison of computational and experimental 
data 
 To glean more detailed information about the solution structure of lipid-free 
SAA, all-atom molecular dynamics (MD) simulations were run using mSAA1, and 
the results are directly correlated with the HDX MS data described in Chapter 5. 
Since the atomic structure of mSAA1 is not known, we used a homology model 




structure for the all-atom simulations of lipid-free mSAA1. The unfolding of the 
mSAA1 monomer is monitored at 37°C, 67°C and 97°C. Based on preliminary 
data, the simulations will be run for 2 µs, during which the root mean square 
fluctuations are expected to level off as a function of time. 
 One complete round of simulations showed that free mSAA1 in solution 
reached a steady state that has ~30% α-helix, comparable to the helical content 
observed by CD at 5°C. Most helical structure was located in h1 and h3, while h2 
and h4 were largely unfolded, which is in agreement with our HDX MS data. 
Interestingly, the preliminary data suggested the formation of a β-hairpin in the h1-
h2 linker as well as a short α-helix in the beginning of h4 (residues 72-76) while 
the rest of h4 is unfolded.  
The simulations are further analyzed by running a cluster analysis to 
characterize the major structural elements in the lipid-free protein (Koike, Ota, & 
Kidera, 2014). This analysis helps better characterize the conformational 
ensemble of free SAA in solution, including the presence of the surprising β-hairpin 
structure in and around the h1-h2 linker and a short helix at the beginning of h4 
linker. Importantly, these well-ordered local secondary structures predicted by MD 
simulations are in excellent agreement with regions of high protection observed in 
SAA in solution by HDX MS (Chapter 5), providing the necessary experimental 
evidence to support the computational results. 
Additional H-bonding and solvent accessibility analyses will be completed 




simulations and the HDX MS data of free SAA. The results are expected to provide 
a detailed understanding of the solution conformation of lipid-free SAA, which is 
the transient structurally labile metabolically active protein form. Moreover, the 
unexpected beta-hairpin structure identified in free SAA monomer, which is 
thought to be the protein precursor of amyloid,  will likely shed new light on the 
early steps in the misfolding pathway of SAA.   
 
6.2.2 Computational analysis of the lipid-binding site in SAA 
 To identify the lipid-binding site in SAA, MD simulations are performed using 
the homology model of mSAA1 added to a pre-equilibrated POPC micelle. In this 
course-grain approach, both mSAA1 and the lipid micelle are treated as rigid 
bodies. The number of contacts that each protein region makes with the micelle is 
monitored as a function of time. To date, we have preliminary data for fully folded 
mSAA1 with the POPC micelle. The initial simulation indicated that most contacts 
between the protein and the lipid were located in residues 5-25 and 54-70 from h1 
and h3, respectively. These preliminary results are in excellent agreement with our 
other studies that identified h1 and h3 as the lipid-binding site.  
 Next, we want to confirm that this binding mode is not limited to the fully-
folded protein conformation, but actually applies to lipid-free SAA that is 25-30% 
helical in solution. Additionally, we want to provide more detailed insights into the 
lipid-induced helical folding. To address these two points, additional molecular 




of free SAA described above where the protein is 30% helical. The starting 
conformation will be chosen by selecting a structure from the most prevalent 
cluster. We expect that MD simulations of this structure in the presence of the 
POPC micelle will reveal lipid-induced helical folding in the c-terminal end of h3 
and perhaps lipid-induced stabilization of the GPGG motif in the h2-h3 linker, as 
suggested by our HDX analysis of Chapter 5.   
 
6.2.3 Towards the structure of SAA-containing lipoproteins 
 Lastly, our biophysical and biochemical studies of SAA-POPC particles 
enabled us to determine the particle size, stability and composition, but we still lack 
the overall structure of these and other SAA-containing lipoproteins. MD will be 
able to help describe how the particles are packed together. For these simulations 
we will introduce multiple SAA molecules to a POPC micelle, but we will no longer 
constrain the vesicle movement. To help refine these structures we will use 
constraints provided by small-angle x-ray scattering (SAXS) experiments, which 
will be run by our new collaborator Dr. Soren Midtgaard. SAXS data will provide 
experimental guidelines for the overall molecular architecture of the SAA-POPC 
complexes, such as the particle size and structural homogeneity, the location of 
the protein on the particle surface, lipid packing in a bilayer versus micellar 
configuration, etc. These studies will enable us to determine, for the first time, the 





6.3 Implication for SAA function in health and disease 
 The results presented in this dissertation provide an important structural 
basis to answer two major questions about SAA physiology: 1) what is the 
primordial function of SAA and 2) how does SAA contribute to the acute-phase 
response? First, our HDX MS results indicate that the SAA regions that are highly 
evolutionally conserved are also particularly highly protected on the lipid and 
apparently form the lipid-binding site. This suggests that the unique helical fold of 
SAA monomer has been conserved throughput evolution to bind lipids and 
sequester them into lipoproteins. We propose that SAA has a complex 
housekeeping role that has evolved over time and is tied to its ability to bind to a 
wide range of lipids. SAA can likely act in various organisms as a “molecular mop” 
by binding to and sequestering free lipids from broken cellular membranes. This 
lipid binding will prevent the inherent “danger signal” of exposed hydrophobic 
segments and reduce the inflammatory response. Additionally, by binding to lipids 
through its concave hydrophobic face as revealed in our studies, SAA will 
sequester lipids into HDL-size nanoparticles and thereby provide the necessary 
curved surface required for phospholipid hydrolysis by secretory phospholipase 
A2. This will enable SAA to act in synergy with this lipase to promote clearance of 
cell debris at areas of inflammation and injury.  
 Second, the major plasma carrier of SAA in humans is HDL. The 
identification of the lipid-binding site as a concaved hydrophobic surface has 




analysis describes how SAA can alter lipoprotein circulation. We show that, while 
the N-terminal two-thirds of the protein, including the h1-h3 segment, form the lipid 
binding site that is well-ordered on the lipid, the C-terminal third is largely 
unordered and is likely to fold upon binding of diverse ligands, including cell 
receptors. The presence of the negatively charged surface comprised of h2 and 
h4, which is solvent-exposed in lipid-bound SAA, may facilitate electrostatic 
interactions with various cell receptors. These receptors including CD36, LOX-1 
and RAGE, which are expressed on the surface of macrophages, will interact with 
SAA, facilitating the uptake of SAA-containing lipoproteins and utilization of their 
lipids for cell repair.  
 Lastly, our results lay the groundwork for future studies to describe the 
pathway of AA amyloid formation. As lipid binding at near-neutral pH stabilizes the 
α-helical structure in the protein, protects it from misfolding in amyloid and delays 
its proteolysis, we have started to describe important residue-specific interactions 
that lead to this lipid-induced protection. This can potentially lead to new protein 
stabilizers that could protect from the formation of AA in patients with chronic 
inflammatory diseases. Finally, our studies at pH~7 can provide the basis for 
detailed studies of protein-lipid interactions at acidic near-lysosomal pH, which we 
know alters the structure-function relationship of SAA, its lipid interactions, and its 
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